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Chapter 1: 
General Introduction 
1. Necrotic enteritis in broilers 
Enteric diseases are an important concern to the poultry industry because of production losses, 
increased mortality, reduced welfare of birds and increased risk of contamination of poultry 
products for human consumption. Necrotic enteritis was first described by Parish (1961) and 
is a common enteric disease, caused by C. perfringens. The disease usually occurs in broiler 
chickens at about 4 weeks after hatching and is found in all poultry-growing areas of the 
world (Long, 1973; Dahiya et al., 2006). 
1.1. Etiology 
Today it is commonly accepted that the bacterium C. perfringens plays an important role in 
the development of necrotic enteritis (Truscott and Al-Sheikhly, 1977; Gholamiandehkordi et 
al., 2007). However, C. perfringens is ubiquitous in the environment and is also a member of 
the normal gut microbiota of vertebrates (Songer, 1996; Porter, 1998). Moreover, chickens 
without C. perfringens among the normal flora are uncommon (Shane et al., 1984; Miwa et 
al., 1997a, b; Craven et al., 2001; Van Immerseel et al., 2004). The intestine of birds suffering 
from necrotic enteritis contains large numbers of C. perfringens, up to 106-108 cfu/g of the 
intestinal contents, whereas in healthy broilers, counts from 0-105 cfu/g of the intestinal 
contents are normal (Long et al., 1974; Baba et al., 1997; Si et al., 2007). However, the 
presence of C. perfringens in the intestinal tract of broiler chickens, even at high numbers, is 
not sufficient to produce necrotic enteritis (Long and Truscott, 1976; Cowen et al.; 1987, 
Kaldhusdal et al., 1999; Craven, 2000; Pedersen et al., 2003; Nauerby et al., 2003). Therefore, 
it is generally accepted that predisposing factors or risk factors are required for these bacteria 
to cause disease. 
Chapter 1: General Introduction 
4 
The key risk factor for the development of necrotic enteritis is an intestinal environment that 
favors growth of the organism. The best-known predisposing factor is mucosal damage 
caused by coccidial pathogens (Williams, 2005). Coccidiosis is often seen to proceed or occur 
concurrent with field outbreaks of necrotic enteritis (Long, 1973; Broussard et al., 1986; 
Gazdzinski and Julian, 1992; Porter, 1998). Moreover, it is shown in experimental infection 
studies that C. perfringens and Eimeria act synergistically in inducing necrotic enteritis 
lesions. Coinfection with C. perfringens and Eimeria oocysts or commercial coccidiosis 
vaccines containing attenuated Eimeria strains result in more animals with lesions or in higher 
mortality rates compared with birds receiving only Eimeria or only C. perfringens (Al-
Sheikhly and Al-Saieg, 1980; Shane et al., 1985; Baba et al., 1997; Gholamiandehkordi et al., 
2007; Park et al., 2008; Pedersen et al., 2008). Eimeria parasites colonize the small intestine 
and kill epithelial cells as a consequence of the intracellular stages of their life cycle. Through 
the resulting gaps in the epithelial lining of the intestinal lumen, plasma proteins are leaking 
into the gut lumen and these can be used as growth-substrate by C. perfringens strains (Van 
Immerseel et al., 2004). Moreover, coccidial infection induces a T-cell mediated 
inflammatory response that enhances intestinal mucogenesis. This enhanced mucus 
production provides a growth advantage to C. perfringens due to its ability to use mucus as a 
substrate (Collier et al., 2008). It is pertinent to note that C. perfringens is auxotrophic for 
thirteen amino acids (Shimizu et al., 2002; Myers et al., 2006), an increase in available 
nutrients would thus allow C. pefringens to proliferate extensively. Furthermore, Park et al. 
(2008) suggested that the exacerbated pathological findings after co-infection with Eimeria 
and C. perfringens are caused by an altered cytokine response. 
 
The nature of the diet is an important non-bacterial factor that influences the incidence of 
necrotic enteritis. Diets with high levels of indigestible, water-soluble non-starch 
polysaccharides predispose to necrotic enteritis. So, wheat, rye, oat, and barley are risk factors 
for necrotic enteritis, whereas maize is not (Branton et al., 1987; Hofshagen and Kaldhusdal, 
1992; Kaldhusdal and Hofshagen, 1992; Kaldhusdal and Skjerve, 1996; Riddell and Kong, 
1992; Craven, 2000; Jia et al., 2009). Some of these effects may be related to differences in 
digesta viscosity, decreased nutrient digestibility and prolonged intestinal transit time (Choct 
et al., 1996). High dietary concentrations of animal protein, such as fishmeal, have also been 
reported to increase the incidence of necrotic enteritis (Truscott and Al-Sheikhly, 1977; Drew 
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et al., 2004; Gholamiandehkordi et al., 2007). In general, protein-rich diets containing 
relatively high concentrations of poorly digestible proteins lead to high concentrations of 
protein in the gastrointestinal tract and thus act as substrates for the bacteria (Williams et al., 
2001). The dietary fat source also inflicts on the C. perfringens population. Animal fat 
increases C. perfringens counts compared to vegetable oil (Knarreborg et al., 2002). Even the 
physical form of the feed may influence the incidence of necrotic enteritis. Mashed feeds are 
associated with higher numbers of C. perfringens in the digestive tract compared to pelleted 
feed (Engberg et al., 2002). Mortality due to necrotic enteritis was higher in groups fed a 
hammer-mill diet compared to groups fed a roller-mill diet (Branton et al., 1987). The feed 
particle size in mashed feed and hammer-mill feed varies widely around the geometric mean, 
it thus contains some large-sized and many small-sized particles. In contrast, feed particles are 
uniform in size in pelleted feed and roller-mill feed. 
Apart from Eimeria infections and the feed, any factor that causes stress in broiler chickens 
could predispose them to necrotic enteritis because it could alter the intestinal environment in 
such a way that the risk of necrotic enteritis occurring is elevated. Programmed alterations in 
the feeding regime (moving from starter diets to grower diets), are frequently associated with 
necrotic enteritis. Furthermore, immunosuppressive agents such as chick anaemia virus, 
Gumboro disease or Marek’s disease, reduces resistance to gut infections and may increase 
the severity of disease. Also physical rupture of the gastrointestinal tract by rough litter and 
increases in stocking density predispose to necrotic enteritis (McDevitt et al., 2006). 
It is thus generally accepted that any factor that may increase the C. perfringens counts in the 
intestine is a risk factor for the development of necrotic enteritis. Nevertheless, as stated 
above, presence of C. perfringens in high numbers is not sufficient to produce necrotic 
enteritis. Therefore, additional, unknown factors determine if necrotic enteritis develops. 
1.2. Clinical signs and gross lesions 
Many signs of necrotic enteritis are aspecific. Birds are depressed, reluctant to move, and 
have ruffled feathers and drooping wings and head. They may be somnolent, diarrheic, 
anorexic, and dehydrated and they can emit a foul smell (Helmboldt and Bryant, 1971; Long 
1973; Van Immerseel et al., 2004). The disease can occur in two forms, it may present as 
acute clinical disease or sub-clinical disease.  
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1.2.1. Clinical necrotic enteritis 
The acute clinical form of the disease is characterized by a sudden increase in flock mortality, 
often without premonitory signs, although wet litter is sometimes an early indicator of 
disease. The course is often peracute, with death in 1-2 h. Mortality may sometimes exceed 
1% daily and the duration of the outbreak in a flock is normally one week (Helmboldt and 
Bryant, 1971). 
Gross lesions are usually restricted to the small intestine, but lesions can also occur in other 
organs, such as caeca, liver and kidney. Upon necropsy, the duodenum, jejunum and ileum are 
usually thin walled and filled with gas. Confluent mucosal necrosis of large parts of the small 
intestine, covered by a yellow-brown or bile-stained pseudomembrane, is found (Figure 1A) 
(Helmbold and Bryant, 1971; Long et al., 1974; Broussard et al., 1986; Olkowski et al., 
2006). 
 
   
Figure 1: A. Confluent necrosis of the jejunum B. Focal necrosis of the jejunum 
1.2.2. Sub-clinical form of Clostridium perfringens infection 
In the sub-clinical form, the clinical signs are milder and usually there is no peak mortality. 
Intestinal damage leads to production losses due to decreased digestion and absorption, 
reduced growth-rate and increased feed-conversion ratio. Ulcers in the form of a depression in 
the mucosal surface, with discolored, amorphous material adhering to the mucosal surface are 
typical for these cases (Figure 1B) (Kaldhusdal and Hofshagen, 1992). Also mucosal gizzard 
lesions have been associated with C. perfringens infection, although it remains unclear 
whether C. perfringens is the cause of the gizzard lesions (Novoa-Garrido et al., 2006). 
Moreover, it is shown that C. perfringens is also able to cause a liver-associated disease, 
cholangiohepatitis. Gizzard and liver lesions are found during meat inspection at slaughter, 
often without any sign of clinical disease in the flock. This increases the number of 
B A 
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condemnations at processing (Onderka et al., 1990; Løvland and Kaldhusdal, 1999; Sasaki et 
al., 2000). There is a general consensus that, although clinical outbreaks of necrotic enteritis 
may cause high levels of mortality, the sub-clinical form of the disease is more important than 
the clinical form because it may persist in broiler flocks without overt clinical manifestations. 
Since the disease is undetected and birds remain untreated, sub-clinical necrosis causes the 
greatest economic losses in the poultry production industry (Kaldhusdal and Hofshagen, 
1992; Dahiya et al., 2006). 
1.3. Histopathology 
Microscopic examination of early stages of necrotic enteritis show strong inflammatory 
reactions to C. perfringens. The lamina propria is hyperemic and infiltrated with numerous 
inflammatory cells. Most significant changes are seen at the interface of the basal domain of 
enterocytes and lamina propria. These areas are extensively edematous, allowing for the 
substantial disturbance of the structural integrity between the lamina propria and the 
enterocytes (Olkowski et al., 2006). Microscopic examination of later stages of necrotic 
enteritis lesions shows diffuse and severe coagulative necrosis of the mucosa, involving the 
luminal third to half of the mucosa. Necrosis of enterocytes in these areas is apparent on the 
villi. A clear line of demarcation between necrotic and viable tissue and an accumulation of 
heterophilic granulocytes at the junction is seen. If present, the pseudomembrane consists of 
masses of tissue fragments, necrotic cells, cell debris, and numerous bacterial colonies 
suspended in mucus. Congestion of blood vessels is seen in the lamina propria and 
submucosa. Large Gram-positive rods are associated with areas of necrosis but do not invade 
the epithelium or are never found to be attached to the viable mucosal epithelial cells, despite 
their massive presence in the lumen tissue debris (Helmboldt and Bryant, 1971; Long et al., 
1974; Al-Sheikhly and Al-Saieg, 1980; Broussard et al., 1986; Olkowski et al., 2006). 
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2. Role of Clostridium perfringens in the pathogenesis 
of necrotic enteritis 
C. perfringens was first described as Bacillus aerogenes capsulatus in 1892 and has also been 
commonly known as C. welchii (Hatheway, 1990). C. perfringens may be the most widely 
occurring bacterial pathogen in nature (Songer, 1996). The bacterium is commonly found in 
soil and sewage and is a normal microbiota component of the intestinal tract of warm-blooded 
animals and men. C. perfringens has been shown to be a cause of human diseases, including 
gas gangrene, necrotic enteritis and food poisoning. It is also the most important cause of 
clostridial enteric disease in domestic animals (Rood and Cole, 1991; Songer, 1996; Rood, 
1998). 
2.1. Basic characteristics 
Clostridium perfringens is a Gram-positive, rod-shaped bacterium. The rods are relatively 
large: 0.6-2.4 x 1.3-19.0 µm (Cato et al., 1986; Hatheway, 1990). C. perfringens has no 
flagella but it is motile by way of type IV pili (Varga et al., 2006). It is classified as an 
anaerobe, although C. perfringens is less strictly anaerobic than other Clostridia (Cato et al., 
1986; Novak and Juneja, 2002). C. perfringens can survive under extreme conditions, due to 
its differentiation from vegetative cells to highly resistant dormant spores (Novak and Juneja, 
2002). Growth has been shown at temperatures as high as 50 °C, while slowly arresting near 
6 °C and below. Under optimal conditions (43-45 °C), C. perfringens is known as the most 
rapidly multiplying organism with generation times often less than 10 min and growth is 
accompanied by abundant gas production. Growth is limited at pH-values lower than 5.0 or 
higher than 8.0 and optimal growth is between pH 6 and 7 (Cato et al., 1986; Novak and 
Juneja, 2002). Genome analysis has revealed that C. perfringens lacks the genetic machinery 
to produce 13 essential amino acids (Shimizu et al., 2002; Myers et al., 2006). As a 
consequence, C. perfringens is not able to grow in an environment where amino acids are 
limiting and it can obtain these via the action of exotoxins, some of which are enzymes.  
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2.2. Virulence factors 
C. perfringens does not invade healthy cells but produces an intimidating arsenal of toxins 
and enzymes that are responsible for the associated lesions and symptoms (Petit et al., 1999). 
2.2.1. Toxins 
The C. perfringens toxins are classified in major toxins, an enterotoxin and minor toxins 
(Hatheway et al., 1990). Individual strains produce only portions of this toxin repertoire and 
the ability of C. perfringens to cause disease is ascribed mainly to the differential production 
of four major toxins, an enterotoxin, and 9 minor protein toxins (Hatheway, 1990; Songer, 
1996; Rood, 1998). 
2.2.1.1. Major toxins 
The major toxins are alpha, beta, epsilon, and iota toxin, all potentially lethal depending on 
the host. The bacterium is classified into 5 types (A through E) according to different 
combinations of production of the four major toxins, as shown in Table I (Sterne and 
Warrack, 1964; Songer, 1996). 
 
Table I: Toxins used for typing C. perfringens (Petit et al., 1999). 
 
Toxin(s) produced 
 
Type 
 
alpha toxin 
 
beta toxin 
 
epsilon toxin 
 
iota toxin 
 
A 
 
+ 
 
- 
 
- 
 
- 
B + + + - 
C + + - - 
D + - + - 
E + - - + 
 
gene 
 
plc 
 
cpb1 
 
etx 
 
iap, ibp 
location chromosome plasmid plasmid plasmid 
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C. perfringens toxin genes are located on the chromosome or on plasmids. The alpha toxin 
gene is located in a very stable region on the C. perfringens chromosome (close to the origin 
of replication) and this is why all C. perfringens strains carry this gene and why it is produced 
in varying amounts by all isolates (Canard and Cole, 1989). Clostridium perfringens 
phospholipase C (alpha toxin) is a Zn2+ metalloenzyme that degrades both lecithin and 
sphingomyelin. It promotes membrane disorganization resulting in lysis or other forms of 
cytotoxicity. Alpha toxin displays platelet aggregating, haemolytic, necrotic, and vascular 
permeabilization activities (Songer, 1997; Rood, 1998; Titball, 1999; Sakurai et al., 2004; 
Flores-Díaz et al., 2004). It is the main virulence determinant in gas gangrene, which is a life-
threatening infection with fever, pain, edema, myonecrosis and gas production. It is shown 
that mutated strains that are unable to produce alpha toxin failed to cause this disease in mice 
(Awad et al., 1995; Flores-Díaz and Alape-Girón, 2003). Beta toxin is a protease-sensitive 
pore-forming toxin. It forms pores by the formation of toxin multimers in the cell membrane, 
resulting in Ca2+, Na+, and Cl- influx and K+ efflux from the cells (Steinthorsdottir et al., 
2000; Shatursky et al., 2000; Nagahama et al., 2003). Epsilon toxin acts by forming large 
membrane pores by oligomerization into a heptamer resulting in potassium and fluid leakage 
of cells, which leads to the loss of cell viability (Petit et al., 2001; Miyata et al., 2001; Petit et 
al., 2003). The beta and epsilon toxins seem to have key roles in enterotoxaemia in calves, 
lambs, piglets and goats, and most of the domesticated livestock in developed countries are 
immunized against disease with toxoid vaccines. Iota toxin is a binary toxin, it consists of two 
independent components, the enzymatic component (Ia) and the binding component (Ib). Ia is 
an ADP-ribosyltransferase that modifies actin. The iota toxin is the only C. perfringens toxin 
that acts intracellularly. All other toxins interact with the cell membrane leading to membrane 
disruption or pore formation (Rood and Cole, 1991; Songer, 1996; Petit et al., 1999; Gibert et 
al., 2000; Marvaud et al., 2001). 
2.2.1.2. Enterotoxin 
Enterotoxin is the cause of human food poisoning. Unlike the other toxins, enterotoxin is not 
secreted but is produced during sporulation (Adak et al., 2002; Brynestad and Granum, 2002; 
Lukinmaa et al., 2002). It interacts with epithelial tight junction proteins and induces leakage 
of water and ions by forming pores or channels in plasma membranes of host cells (McClane, 
2001, Smedley et al., 2004). 
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2.2.1.3. Minor toxins 
All other toxins belong to the group of minor toxins. Theta toxin, also known as theta-
hemolysin, perfringolysin O, or the thiol-activated cytolysin is located on the chromosome 
and produced by all five toxin types of C. perfringens (Rood and Cole, 1991). Theta toxin is a 
member of the cholesterol-binding toxin family and causes complete hemolysis of red blood 
cells by forming oligomers, which subsequently form pores through the cell membrane (Petit 
et al., 1999, Awad et al., 2001). A more recently discovered toxin is Beta2 toxin, a pore-
forming toxin that is associated with enteritis in neonatal pigs (Gibert et al., 1997; Jost et al., 
2005). Other known toxins produced by C. perfringens are: delta toxin, a hemolysin; kappa 
toxin, a collagenase; lambda toxin, a caseinase; mu toxin, a hyaluronidase; nu toxin, a 
nuclease; neuraminidase or sialidase, a N-acetylneuraminic acid glycohydrolase; and the 
gamma and eta toxins, whose function is unclear (Hatheway, 1990; Rood and Cole, 1991). 
The relevance in disease of most of these minor toxins is not fully understood. 
 
The different toxin types of C. perfringens are associated with particular human or veterinary 
diseases (Table II), indicating that variations in toxin production profoundly influence the 
virulence properties of C. perfringens isolates. These isolate-to-isolate differences in toxin 
production also help explain the pathogenic versatility of C. perfringens, which causes both 
enteric and histotoxic infections and has a disease spectrum ranging from low incidence/high 
mortality to high incidence/low mortality. Strains of toxin type B-E are always associated 
with disease processes, indicating that they are frank pathogens. Type A strains are also 
associated with disease but can equally well be part of the normal flora in the intestinal tract 
of man and animal (Hatheway, 1990; Songer, 1996). Rather than being a function of a single 
toxin, the virulence of different C. perfringens isolates is considered as a multifactorial trait, 
with different determinants contributing to adaptation of the organism to its niche and to 
production of the pathology (Canard et al., 1992; Miyamoto et al., 2006; Sawires and Songer, 
2006). The pathogenesis of C. perfringens in different diseases has not yet been fully 
elucidated and probably many potential toxins are yet unidentified. 
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Table II: Diseases associated with C. perfringens toxin types A, B, C, D, and E (Hatheway 
1990, Songer 1996, Petit et al. 1999, Smedley et al. 2004). 
                                                Diseases Toxin 
type Human Animal 
 
A 
 
gas gangrene 
 
necrotic enteritis (fowl) 
mild necrotizing enteritis (piglets) 
enterotoxaemia (various animals) 
acute gastric dilatation (various animals) 
intestinal clostridiosis (horses) 
A (β2, CPE) food poisoning 
non-foodborne gastrointestinal disease 
diarrhea (various animals) 
A (CPE) non-foodborne gastrointestinal disease  
A (β2)  enteritis (various animals) 
B  dysentery (newborn lambs) 
chronic enteritis (older lambs) 
hemorrhagic enteritis (calves, foals) 
enterotoxaemia (sheep, goats, guinea pigs) 
C necrotizing enteritis 
(i.e. pigbel, darmbrand) 
enterotoxaemia (pigs, lambs, calves, goats, fowl) 
struck (acute enterotoxaemia in sheep) 
C (β2)  enteritis (pigs) 
D  pulpy kidney disease (lambs and calves) 
enterocolitis (goats, cattle) 
E  enteritis (dogs, cattle, pigs) 
enterotoxaemia (calves, guinea pigs, rabbits) 
dysentery (lambs)  
CPE: enterotoxin 
2.2.1.4. The role of alpha toxin in necrotic enteritis 
It is generally accepted that C. perfringens type A is the causative agent of both clinical and 
sub-clinical necrotic enteritis since strains isolated from birds suffering from necrotic enteritis 
all belong to toxinotype A (Engström et al., 2003; Nauerby et al., 2003; Gholamiandehkordi 
et al., 2006; Chalmers et al., 2008a). Moreover, clinical and sub-clinical necrotic enteritis 
were experimentally reproduced using C. perfringens type A (Al-Sheikhly and Truscott, 
Chapter 1: General Introduction 
13 
1977a; Al-Sheikhly and Truscott, 1977c; Gholamiandehkordi et al., 2007). Of the major 
typing toxins, type A strains produce only alpha toxin. Therefore, for a long time it was 
thought that alpha toxin was the major virulence factor in the pathogenesis of necrotic 
enteritis in poultry. Several studies presented evidence for this hypothesis. Bacteria-free crude 
supernatant from C. perfringens type A cultures produced necrotic lesions in broilers (Al-
Sheikly and Truscott, 1977b) or caused mortality in germ-free chickens (Fukata et al., 1988). 
After addition of antibodies to C. perfringens alpha toxin to the supernatant no mortality was 
seen (Fukata et al., 1988). Lovland et al. (2004) showed that maternal vaccination with a 
crude C. perfringens type A and C toxoid induces antibodies against alpha toxin in chicks, 
which are partially protective against necrotic enteritis. However, care must be taken when 
interpreting these studies. Hence, crude supernatant was used and the assumption that the 
observed effects were caused by the dominant protein present in the supernatant (i.e. alpha 
toxin) did not take into account other secreted toxins that the bacteria may have produced. 
Epidemiological and experimental evidence has supported the proposal that alpha toxin is an 
important protective antigen. High titers of antibodies to alpha toxin are found in poultry 
immune to necrotic enteritis (Heier et al., 2001; Kulkarni et al., 2006). Moreover, 
immunization of broilers with purified alpha toxoid induced protection against experimentally 
induced necrotic enteritis (Kulkarni et al., 2007). Thompson et al. (2006) showed that 
spontaneously derived alpha toxin mutants of a virulent strain have an impaired ability to 
cause NE lesions. However, since it were spontaneously derived mutants, the reduced 
virulence could be due to the impairment of the production of other toxins than alpha toxin. 
Against this background, the role of alpha toxin in the pathogenesis of necrotic enteritis was 
called somewhat into doubt at the start of this thesis. C. perfringens outbreak strains as well as 
normal broiler microbiota isolates are type A (Nauerby et al., 2003; Gholamiandehkordi et al., 
2006). Moreover, no apparent difference in the levels of alpha toxin was found when the 
alpha toxin production in vitro was compared between strains associated with necrotic 
enteritis and isolates derived from the microbiota of normal broilers (Gholamiandehkordi et 
al., 2006). Yet another study found that the intestinal level of alpha toxin was not correlated 
with disease lesion scores (Wilkie et al., 2006). More convincing evidence was produced by 
Keyburn et al. (2006). They showed that an alpha toxin mutant, constructed from a virulent 
chicken isolate, was equally able to cause necrotic lesion in broiler chickens compared to the 
wild-type strain (Keyburn et al., 2006). Another observation that argues strongly against the 
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role of alpha toxin in necrotic enteritis is the massive heterophil, lymphocyte, and plasma cell 
infiltration in infected tissues (Al-Sheikhly and Truscott, 1977b; Gazdzinsky and Julian, 
1992; Shane et al., 1985). In gas gangrene, a disease proved to be mediated by alpha toxin, 
marked leukostasis and lack of inflammatory infiltrate is common in tissues infected by 
C. perfringens cells (Flores-Díaz and Alape-Girón, 2003). Alpha toxin-negative mutants of 
C. perfringens are not able to cause gas gangrene in mice but do promote profound 
inflammatory responses (Awad et al., 1995). Thus, the massive immune-cell influx in necrotic 
enteritis lesions seems to be inconsistent with the known effects of alpha toxin on the innate 
immune system.  
2.2.2. Proteolytic enzymes 
Recent studies of initial stages of the disease process have provided new etiological details on 
the development of necrotic enteritis in broilers. Olkowski et al. (2006, 2008) showed that 
damage to the villi initially occurs at the level of the basement membrane and lateral domain 
of the enterocytes, spreading throughout the lamina propria, while epithelial damage occurs 
later in the process. The nature of the morphological changes indicates that the initiation of 
the pathological process leading to necrotic enteritis involves proteolytic factors affecting the 
extracellular matrix and cellular junctions. Indeed, in broilers undergoing necrotic enteritis, 
the extracellular matrix is disorganized and can even be completely absent. It was shown that 
C. perfringens strains isolated from field cases of necrotic enteritis secrete several potent 
collagenolytic enzymes and that broilers challenged with C. perfringens show elevated levels 
of several collagenolytic enzymes in the intestinal tissue in comparison to controls. It was 
thus suggested that the pathology may be the result of bacterial collagenases, whose action is 
enhanced when mucosal damage (e.g. induced by coccidia) is present, or of host matrix 
metalloproteinases that are activated by the host-pathogen interaction (Olkowski et al., 2008). 
From this point of view, it is interesting to note that one of the recently identified, potentially 
protective vaccine antigens from C. perfringens might be a zinc metallopeptidase (Kulkarni et 
al, 2007).  
2.3. Genetic diversity 
The genetic diversity among C. perfringens isolates originating from humans, calves, pigs, 
sheep, rabbits, goats, poultry, horses, roe deer and food has been investigated by pulsed-field 
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gel electrophoresis (PFGE). In all cases a high degree of genetic diversity was found (Canard 
et al., 1992; Maslanka et al., 1999; Nauerby et al., 2003; Johansson et al., 2006; 
Gholamiandehordi et al., 2006). Ribotyping of C. perfringens isolates obtained from food also 
confirmed a great diversity (Schalch et al., 1999; Kilic et al., 2002). Using multiple-locus 
variable-number tandem repeat analysis (MLVA), Sawires and Songer (2006) and Chalmers 
et al. (2008b) showed also a lack of association between strain phylogeny and host species of 
disease. Isolates of common host origin did not cluster, while isolates from diverse animal 
origins were sometimes the same MLVA type. Moreover, some normal flora strains from 
certain host species are phylogenetically close to genotypes of virulent strains from a different 
host species. 
The entire genome sequence of three different C. perfringens type A strains has been 
published (Shimizu et al., 2002; Myers et al., 2006). The sequenced strains are a gangrene 
strain (ATCC 13124) and a food poisoning strain (SM101) isolated from humans and a soil 
isolate that is able to induce gas gangrene in mice (strain 13). Comparison of the three 
genomes revealed considerable genomic diversity with discrete islands containing genes 
likely to confer specific virulence, metabolic, or catabolic capabilities to the host strain. This 
enables C. perfringens to adapt to a variety of environmental conditions and explains the 
different virulence characteristics of C. perfringens (Myers et al., 2006). C. perfringens toxin 
genes are located on the chromosome or on plasmids. The genomic diversity of C. perfringens 
seen during typing could be the result of the presence of toxin genes on extrachromosomal 
elements. It seems to be the case that, by acquisition of extrachromosomal elements 
(plasmids, transposons and possibly phages) containing additional toxin genes, different 
C. perfringens types have been derived from the type A strain (Petit et al., 1999). Moreover, 
Sawires and Songer (2006) suggested that acquisition of the major toxin genes as well as 
other plasmidborne toxin genes is a recent evolutionary event and that their maintenance is 
essentially a function of the selective advantage they confer in certain niches under different 
conditions 
2.4. Single strain dominance in broiler necrotic 
enteritis 
Genetic characterization by PFGE or amplified fragment length polymorphism (AFLP) has 
revealed that in healthy flocks, different genotypes of C. perfringens type A can be found, 
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even within individual birds and within the same gut segment. In contrast, outbreak isolates 
from a flock with necrotic enteritis or cholangiohepatitis are generally clonal, regardless of 
the animal or the organ of isolation (Engström et al., 2003; Nauerby et al., 2003; 
Gholamiandehkordi et al., 2006). These results were confirmed by multilocus sequence typing 
analysis (MLST) (Chalmers et al., 2008a). After natural recovery or treatment, birds again 
yield multiple genetic types (Nauerby et al., 2003). The reason for the selective presence of a 
single clone in necrotic enteritis outbreaks is not known. It is possible that during an outbreak, 
certain C. perfringens strains are able to secrete growth-inhibiting molecules which give them 
a competitive advantage over other C. perfringens strains in the broiler gut. Indeed, inhibiting 
other strains could lead to extensive and selective presence of a strain that contains the genetic 
make-up to secrete toxins that cause gut lesions. 
3. Antimicrobial proteins from bacteria 
Antimicrobial peptides and proteins are produced by all species of life (prokaryotic and 
eukaryotic): plants, insects and other invertebrates, fish, amphibians, birds, mammals - 
including humans, and different microorganisms (Nissen-Meyer and Nes, 1997; Jenssen et al., 
2006).  In higher organisms these compounds are produced as an innate host defense 
mechanism to protect against pathogenic attack, whereas microorganisms presumably use 
these compounds as weapons in the competition for space and nutrients among bacteria living 
in the same ecological niche. Although they differ greatly in their primary structures, they are 
nearly all fairly short molecules, cationic and very often amphiphilic (i.e. it possesses both 
hydrophobic and hydrophilic properties). This is reflected in the fact that many of these 
peptides kill their target cells by permeabilizing the target cell membrane, resulting in an 
irreversible leakage of cellular material and consequently cell death (Nissen-Meyer and Nes, 
1997). Other modes of action such as the inhibition of nucleic acid synthesis, protein 
synthesis, enzyme activity and cell wall synthesis have been described (Brogden, 2005). The 
antimicrobial proteins and peptides from bacteria include toxins, antibiotics, bacteriolytic 
enzymes, bacteriocins, and bacteriocin-like peptides (Jack et al., 1995).  
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3.1. Bacteriocins 
Bacteriocins are defined as a heterogeneous group of ribosomally synthesised, proteinaceous 
substances (with or without further modifications) produced by bacteria that kill or inhibit the 
growth of other bacteria. Their mode of activity is primarily bactericidal and directed against 
closely related strains and species. The bacteriocin family includes a diversity of peptides and 
proteins in terms of size, amino acid sequence and composition, secretion and processing 
machinery, post-translational modifications, microbial target, mode of action, and 
mechanisms of resistance (Klaenhammer, 1993; Jack et al., 1995). 
Bacteriocins were first identified in Gram-negative bacteria over 80 years ago when inhibition 
was observed between two strains of Escherichia coli (Gratia, 1925). A heat labile product 
present in cultures of Escherichia coli V was shown to be toxic to E. coli S and it was named 
colicin (Gratia, 1925). Fredericq (1946) demonstrated the protein nature of colicins and their 
limited range of activity due to the presence or absence of specific receptors on the surface of 
sensitive cells (Fredericq, 1946). Since then, bacteriocins have been found in all major 
bacterial lineages and, more recently, some members of the Archaea have also been seen to 
produce similar antimicrobial proteins (O’Connor and Shand, 2002). According to 
Klaenhammer (1988), 99% of all bacteria may produce at least one bacteriocin, and the only 
reason why there have not been isolated more is that few researchers have looked for them. 
Since bacteriocin production is detected in all surveyed lineages of prokaryotes, bacteriocins 
must serve some function in microbial communities (Klaenhammer, 1988). They may play a 
defensive role by inhibiting the invasion of other strains or species into an occupied niche or 
they may serve as anti-competitors enabling the invasion of a strain into an established 
microbial community (Riley and Wertz, 2002). Additional roles have been proposed; they 
may mediate quorum sensing by acting as a signal molecule that induces the transcription of 
genes involved in its biosynthesis and they may act as communication signals in bacterial 
consortia e.g. biofilms (Gobbetti et al., 2007; Gillor et al., 2008).  
Bacteriocins can be divided into two main groups: those produced by Gram-negative and 
Gram-positive bacteria (Gillor et al., 2008). Within the scope of the thesis we will focus on 
bacteriocins of Gram-positive bacteria. 
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3.2. Bacteriocins of Gram-positive bacteria  
3.2.1. General characteristics 
Bacteriocins of Gram-positive bacteria are abundant and diverse. They resemble many of the 
antimicrobial peptides produced by eukaryotes; they are generally cationic, amphiphilic, heat 
stable, membrane-permeabilizing peptides, and smaller than 8 kDa (Maqueda et al., 2008). 
However, some Gram-positive bacteria have been shown to form relatively high-molecular-
weight, heat labile bacteriocin-like substances (Jack et al., 1995). Although by definition all 
bacteriocins have a protein or peptide component that is essential for their bactericidal 
function, some have been reported to consist of combinations of different proteins, or are 
composites of proteins together with lipid or carbohydrate moieties (Jack et al., 1995). 
Bacteriocins can specifically target a particular subset of bacterial strains or species. The 
conventional wisdom about the spectrum of Gram-positive bacteriocins is that they are 
restricted to killing other Gram-positives (Gillor et al., 2008). However, the range of killing 
can vary significantly, from relatively narrow to extraordinarily broad. Some bacteriocins are 
only active against closely related strains, others against a wide range of Gram-positive 
bacteria and some are even able to inhibit Gram-negative species (Morency et al., 2001). 
Interpretation of spectra of inhibitory activity in terms of specific bacteriocin activities can 
sometimes be difficult if the producer strains release more than one bacteriocin-like agent 
(Higa et al., 1991). 
Many bacteriocins appear to elicit their lethal effects by permeabilizing the cell membrane of 
target organisms, in certain cases by targeting intermediates of cell wall biosynthesis or 
possibly proteins of sugar phosphotransferase systems (Garneau et al., 2002). Creating pores 
in the membrane of target cells has deleterious effects such as dissipation of proton motive 
force, ATP depletion and leakage of nutrients and metabolites. The size, stability, and 
conductivity of these pores differ considerably from one bacteriocin to another. To form a 
pore, bacteriocins have to interact with the cytoplasmic membrane of target cells. This process 
is at least in part governed by electrostatic interactions between the positively charged peptide 
and the anionic lipids that are abundantly present in the membranes of Gram-positive bacteria 
(Eijsink et al., 2002). Several factors may contribute to making a cell resistant towards 
bacteriocins. The composition and structure of both cell wall and cellular membrane(s) may 
be such that the bacteriocin is physically unable to reach its target. Alternatively, certain 
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cellular components (‘receptors’) that are essential for bacteriocin action may be lacking or 
may be mutated. In some cases, the presence of (aspecific) proteases in and near the target 
cell may reduce bacteriocin effectiveness. Finally, the ease at which a membrane-bound 
bacteriocin actually can form pores can be affected by the physiological state of the target cell 
(Driessen et al., 1995; Eijsink et al., 2002). 
 
Production of bacteriocins in Gram-positive bacteria is generally associated with the shift 
from logarithmic phase to stationary phase. Gram-positive bacteriocins require several genes 
and these bacteriocin-associated genes appear to be characteristically arranged in multigene 
operon-like structures, the first gene typically (but not always) encodes the structural protein 
(Klaenhammer, 1993). Additional genes encode for proteins that aid in the regulation, 
proteins that aid in the processing to the active form, proteins that aid in the transport of the 
bacteriocin across the membrane and proteins that confer immunity to the host producer 
(Engelke et al., 1992; Klein et al., 1993; Engelke et al., 1994; Klein and Entian, 1994; Diep et 
al., 1996; Qiao et al., 1996; Diep et al., 2007; Dufour et al., 2007). Due to these additional 
genes, bacteriocins produced by Gram-positive bacteria are generally not lethal to the 
producing cell. 
3.2.2. Classification 
There is a lack of consensus in the classification of bacteriocins from Gram-positive bacteria. 
Bacteriocins are commonly divided into three or four main categories (Nes et al., 2007; Gillor 
et al., 2008). This classification is based on bacteriocins produced by lactic acid bacteria since 
these are the best characterized of this group. Class I is comprised of lantibiotics. These are 
small, posttranslationally modified peptides that contain unusual amino acids (Guder et al., 
2000; Twomey et al., 2002). Class II includes heat stable non-lantibiotics (Eijsink et al., 2002; 
Héchard and Sahl, 2002; Drider et al., 2006). Larger, heat labile bacteriocins are classified as 
class III. For this category much less information is available than for the first two. Class IV 
is comprised of complex bacteriocins that require lipid or carbohydrate moieties for activity. 
However, presently, no such bacteriocins have been purified and it is suggested that this type 
of bacteriocin is an artefact due to the cationic and hydrophobic properties of bacteriocins 
which result in complexing with other macromolecules in the crude extract (Cleveland et al., 
2001; Garneau et al., 2002; Gillor et al., 2008). Class I and II are subdivided in subgroups. 
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Lantibiotics are posttranslationally modified peptides that contain the unusual amino acids 
lanthionine and β-methyl lanthionine as part of additional intramolecular rings, and often 
possess other modified residues such as dehydro amino acids (Guder et al., 2000; Twomey et 
al., 2002; Nagao et al., 2006). They target a broad range of Gram-positive bacteria and are 
subdivided into three groups on the basis of their structure and mode of action: Type A 
lantibiotics are small (2 - 5kDa), elongated molecules with a flexible structure in solution, that 
contain positively charged molecules, which kill via the formation of pores in the bacterial 
membrane, leading to the dissipation of membrane potential and the efflux of small 
metabolites from the sensitive cells. Type B lantibiotics tend to have a more rigid and 
globular structure. They kill by interfering with cellular enzymatic reactions, such as cell wall 
synthesis (Pag and Sahl, 2002; Garneau et al., 2002). Another subgroup of the lantibiotics is 
composed of two-component lantibiotics, consisting of two lantibiotic peptides that 
synergistically display antimicrobial activity (Breukink, 2006; Wiedemann et al., 2006).   
Class II bacteriocins are small non-lanthionine containing peptides (Garneau et al., 2002; 
Drider et al., 2006). The majority of bacteriocins in this group kill by inducing membrane 
permeabilization and the subsequent leakage of molecules from target bacteria. These 
bacteriocins are organized into four subgroups. Class IIa is the largest group and its members 
share activity against Listeria and a conserved amino-terminal sequence (YGNGVXaaC) that 
is thought to facilitate nonspecific binding to the target surface. Class IIa bacteriocins act 
through the formation of pores in the cytoplasmic membrane. Class IIb bacteriocins are two-
peptide bacteriocins and form cation- or anion-specific pores, composed of two different 
proteins, in the membrane of their target cells (Héchard and Sahl, 2002; Oppegård et al., 
2007). A third subgroup (IIc) has been proposed, which consists of leaderless peptide-
bacteriocins that are secreted via the general secretory (sec) pathway and not having its own 
dedicated and specific mechanism (Nes et al., 1996; Garneau et al., 2002). Circular 
posttranslationally modified bacteriocins are classified in a fourth subgroup (IId) (Nes et al., 
2007).  
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Table III: Classification of bacteriocins 
Type Class Special features 
Lantibiotics IA Posttranslationally modified elongated molecules 
 IB Posttranslationally modified globular molecules 
 IC Two-component lantibiotics 
Small non-lantibiotics IIa Strong antilisterial activity 
Conserved amino-terminal sequence (YGNGVXaaC) 
 IIb Two-peptides 
 IIc No leader 
 IId Circular 
Large heat-labile bacteriocins III Large, heat labile 
Complex bacteriocins IV Carry lipid or carbohydrate moieties 
3.3. Bacteriocins of Clostridium perfringens 
Bacteriocin-like activity in C. perfringens was first observed in a study of the bacteriophages 
of the organism (Smith, 1959). Subsequently, several studies have been carried out to 
examine the ability of C. perfringens strains to produce bacteriocins and to characterize the 
bacteriocins (Rood and Cole, 1991). It is clear that C. perfringens strains produce a large 
number of different bacteriocins that are distinguishable by examination of activity spectra. 
Different typing schemes based on patterns of bacteriocin susceptibility of C. perfringens 
strains or on C. perfringens bacteriocin activity spectra were developed (Mahony, 1974; Satija 
and Narayen, 1980a; Satija and Narayen, 1980b; Scott and Mahony, 1982). A bacteriocin 
typing scheme was used to type human fecal C. perfringens isolates and it was shown that in 
human feces more than one strain of C. perfringens could be carried simultaneously (Mahony 
and Swantee, 1978). Clinical isolates were also typed and it was found that the patterns of 
strains from the same outbreak clustered together while strains from different outbreaks had 
different patterns (Watson et al., 1982; Watson, 1985). Despite the effort of developing typing 
schemes and despite the fact that C. perfringens bacteriocins proofed to be useful to type 
clinical C. perfringens isolates, typing of C. perfringens strains with bacteriocins or on the 
basis of bacteriocin production was never generally in widespread or routine use in clinical 
laboratories (Rood and Cole, 1991). Nowadays, other techniques, such as AFLP, PFGE, and 
MLVA are used to type C. perfringens strains. However, the interest in C. perfringens 
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bacteriocins and the analysis of bacteriocin-encoding plasmids has played a very important 
role in the development of C. perfringens genetics and different C. perfringens bacteriocins 
are described in literature. 
3.3.1. BCN5 
BCN5 (or N5) produced by C. perfringens CPN50 (or C. perfringens BP6k-N5) is the best 
characterized bacteriocin of C. perfringens. BCN5 was first purified by Wolff and Ionesco 
(1975). They found a simple protein with an estimated molecular mass of 82 kDa. The 
purified bacteriocin was inactivated by proteolytic enzymes and was heat labile. Since BCN5 
is a large heat labile bacteriocin, it can be classified as class III bacteriocin according to the 
currently used classification. BCN5 inhibits the initiation of the germination of spores of 
C. perfringens and it inhibits the DNA-, RNA-, and protein synthesis simultaneously in 
sensitive cells, without DNA degradation (Sebald and Ionesco, 1974; Ionesco and Wolff, 
1975). C. perfringens CPN50 produces the bacteriocin upon UV induction (Ionesco and 
Bouanchaud, 1973; Ionesco et al., 1974), which suggest that the production is controlled by 
an SOS-like system and is induced by DNA-damaging treatment (Walker, 1984). Following 
activation of the bcn gene, copious amounts of a 96 kDa protein accumulate in the cytoplasm, 
to be released into the medium 90 to 180 minutes after induction by lysis of the bacteria 
(Ionesco et al., 1974; Garnier and Cole, 1986). From the nucleotide sequence of the bcn gene, 
the primary structure of BCN5 was deduced and revealed a protein with a molecular weight of 
96.591 kDa, with high glycine content (11.5%). This is common for bacteriocins and is 
believed to facilitate their transfer across cell membranes. The primary structure of the protein 
reveals the presence of an extended lipophilic region near the COOH terminus. This suggests 
that it may function as an ionophore (Garnier and Cole, 1986). The discrepancy between the 
estimated molecular weight of 82 kDa by Wolff and Ionesco (1975) could be due to 
proteolytic processing of the 95 kDa precursor molecule (Garnier and Cole, 1986).  
Curing of C. perfringens CPN50 has been accomplished after acriflavine treatment (Ionesco 
and Bouanchaud, 1973). It was shown that these cured derivates produced no longer 
bacteriocin and that this bacteriocin loss was associated with the loss of plasmid DNA 
(Ionesco and Bouanchaud, 1973). Electron-microscopic analysis showed more specifically 
that the loss of both bacteriocin production and immunity to the bacteriocin was associated 
with the loss of a small (5.7 MDa) plasmid, pIP404. Thus, in addition to encoding BCN5, 
Chapter 1: General Introduction 
23 
pIP404 codes for bacteriocin immunity (Ionesco et al., 1976; Brefort et al., 1977). To locate 
the bcn gene on pIP404, differential dot blot hybridization was performed with RNA samples 
prepared from cultures before and after induction with UV irradiation. This approach revealed 
that UV irradiation induces a high rate of transcription of a 4kb segment of pIP404 that 
includes two contiguous transcription units, uviAB and bcn (Garnier and Cole, 1986; Garnier 
and Cole, 1988). The bcn gene, encoding BCN5, is transcribed from three promoters (P1, P2 
and P3) all of which are dependent on UviA for activation. P1, the promoter closest to the 
coding sequence, appears to be the strongest of the three (Dupuy et al., 2005). Transcription 
of uviAB is directed by two promoters (P4 and P5). It was hypothesized that the uviAB operon 
might encode proteins needed for BCN5 synthesis or secretion or for immunity to the 
bacteriocin (Garnier and Cole, 1986; Garnier and Cole, 1988). Dupuy et al. (2005) showed 
that UviA is an RNA polymerase σ factor. Promotor P4 provides an UviA-independent, basal 
level of gene expression while the stronger, UviA-dependent promoter (P5) was only utilized 
after the cell experienced DNA damage. As a result, BCN5 synthesis is induced by treatment 
with UV light or mitomycin C. The role of UviB, the second product of the uviAB operon, 
has never been determined. As BCN5-producing cells are immune to the bacteriocin, UviB 
might be the immunity protein (Dupuy et al., 2005). 
3.3.2. Bacteriocin 28 
Mahony and Butler (1971) screened 33 C. perfringens strains for bacteriocin production and 
four bacteriocin-producing strains were detected. One of the bacteriocins, bacteriocin 28 
produced by C. perfringens strain 28, was chosen by Mahony and associates to study in more 
detail. Bacteriocin production by C. perfringens strain 28 is associated with a 5.6 MDa 
plasmid since a cured variant lost its immunity and its ability to produce bacteriocin (Li et al., 
1980). High titres of bacteriocin 28 are produced during late logarithmic growth although 
higher yields are obtainable by induction with mitomycin C but not with UV light (Mahony 
and Butler, 1971; Mahony, 1977). The bacteriocin was heat labile, only stable at pH between 
5 and 7 and sensitive to the action of trypsin and pronase (Mahony and Butler, 1971; Mahony 
and Li, 1978). Bacteriocin 28 is a glycoprotein with hydrophobic properties and an estimated 
molecular mass of 100 kDa (Li et al., 1982). Like BCN5, bacteriocin 28 is a large heat labile 
bacteriocin and can be classified as class III bacteriocin. Investigation of its mode of action 
indicated that it seemed bacteriostatic and that it does not inhibit the synthesis of DNA, RNA 
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or proteins but acts on the cell wall of viable indicator cultures, causing conversion of 
indicator strains to spheroplasts, either by removing the existing wall or inhibiting cell wall 
synthesis. These spheroplasts are capable of growing as L-form colonies on sucrose 
containing media. Such colonies were composed of spherical and amorphous structures of 
considerable size and demonstrated a dense center containing many granular structures 
(Mahony et al., 1971).  
3.3.3. Other Clostridium perfringens bacteriocins 
Mahony and Li (1978) compared nine other C. perfringens bacteriocins with bacteriocin 28. 
Two bacteriocins were stable over a wide range of pH values and resisted boiling and three 
other bacteriocins were resistant to trypsin. Essentially, the bacteriocins could be divided in 
two major groups, those that inhibit DNA, RNA, and protein synthesis, such as BCN5, and 
those that interfere with the cell wall of sensitive C. perfringens strains, like bacteriocin 28 
(Mahony and Li, 1987; Mahony, 1982). Clarke et al. (1975) described perfringocin 11105. 
This bacteriocin is produced by C. perfringens NCIB11105 and is heat stable, trypsin 
susceptible and stable over a wide range of pH.  It has a molecular weight of 76 kDa and the 
properties of an amphiphilic protein. Perfringocin 11105 is produced at the onset of the 
stationary phase of the C. perfringens culture, and its subsequent production coincides with 
some lysis of the producer organism. Yield of perfringocin 11105 can be enhanced by 
mitomycin C treatment (Clarke et al., 1975). Mihelc et al. (1978) reported that a 5.6 MDa 
plasmid (pCW4) is associated with bacteriocin production and immunity in C. perfringens 
strain CW55. Higa et al. (1991) showed that C. perfringens SN-17 produced two types of 
bacteriocin successively one after the other during late exponential phase, without induction 
by UV radiation or mitomycin C. The molecular weight of SN-a and SN-b was determined to 
be about 70 kDa and 100 kDa respectively. Both bacteriocins were heat labile, sensitive to 
pronase and more stable in alkaline pH than in acidic pH. Both bacteriocins adsorbed to 
resting cells or even dead cells, indicating that they bind to receptors on the surface of 
sensitive cells (Higa et al., 1991). 
3.3.4. Bacteriocin genes in genome sequences 
Analysis of the genome sequences of the three sequenced C. perfringens strains revealed a 
single bacteriocin gene (bcn5) on the chromosome of strain 13 in association with the 
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prophage remnant (Shimizu et al., 2002). No bacteriocin or accessory genes are found in the 
ATCC 13124 genome. By contrast, several bacteriocin loci are found in the SM101 genome 
and plasmid sequences. The two SM101 plasmids each bear a complete UV-inducible 
bacteriocin operon (uviA-uviB-bcn5), similar to the archetypal clostridial bacteriocin bearing 
plasmid pIP404 of CPN50 (Myer et al., 2006). 
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Chapter 2: 
Scientific Aims 
Clostridium perfringens type A is a member of the normal intestinal microbiota but can also 
induce necrotic enteritis in broiler chickens. Necrotic enteritis is characterized clinically by a 
sudden increase in flock mortality, often without premonitory signs. Also a sub-clinical form 
of necrotic enteritis is described. At necropsy, necrotic foci are found in the small intestinal 
mucosa. Despite the clinical and economic importance of necrotic enteritis, the pathogenesis 
of C. perfringens associated disease in poultry is still not fully understood. For that reason, the 
general aim of this work was to get more insight into the pathogenesis of necrotic enteritis. 
C. perfringens is associated with necrotic enteritis but can also be detected in high numbers in 
the intestinal tract of apparently normal birds. Consequently, the first aim of this works 
(Chapter 3.1) was to compare C. perfringens isolates from both clinically healthy broilers 
and broilers suffering from necrotic enteritis for their ability to induce necrotic enteritis using 
an experimental necrotic enteritis model in broiler chickens. 
Clinically healthy chickens can carry several different C. perfringens clones in their intestine. 
However, in flocks suffering from necrotic enteritis mostly only one single clone is isolated 
from the gut of all the diseased animals. The reason for the presence of a single clone in 
necrotic enteritis outbreaks is not known. 
Therefore the second aim of this study (Chapter 3.2) was to compare virulent and avirulent 
C. perfringens isolates for their ability to inhibit the growth of other C. perfringens strains 
using a lawn-spotting test. The identification of the factor(s) responsible for growth-inhibition 
was the third aim of the study (Chapter 3.3). 
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Abstract 
Since the ban on growth-promoting antibiotics in animal feed in the European Union, necrotic 
enteritis has become a major cause of mortality in broiler chickens. Despite the importance of 
the disease, the pathogenesis is still not completely understood. In the current study, 
Clostridium perfringens strains isolated from healthy flocks and isolates from outbreaks of 
necrotic enteritis were evaluated for the ability to cause gut necrosis in an intestinal loop 
model in laying hens and in an experimental infection model in broilers. High, intermediate 
and low alpha toxin producing strains were chosen from each isolation source. Only the 
isolates from field outbreaks induced necrotic gut lesions, independent of the amount of alpha 
toxin produced in vitro. It was also shown that alpha toxin producing isolates from calf 
hemorrhagic enteritis cases were not able to induce necrotic enteritis in poultry. These results 
suggest the presence of host specific virulence factors in Clostridium perfringens strains, 
isolated from chickens with intestinal necrotic enteritis lesions. 
 
Key words: Clostridium perfringens; Broiler; In vivo; Alpha toxin; Host specificity 
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1. Introduction 
Clostridium perfringens is a Gram-positive spore-forming anaerobic bacterium that is 
commonly found in soil and sewage and in the gastro-intestinal tract of animals and humans 
as a member of the normal gut microbiota (Hatheway, 1990; Songer, 1996). C. perfringens 
strains are classified into five types (A-E) on the basis of the production of four major toxins 
(known as the alpha, beta, epsilon and iota toxins) (McDonel, 1980; Petit et al., 1999). 
Necrotic enteritis in poultry is an enteric disease which is caused by C. perfringens type A 
(Engström et al., 2003; Nauerby et al., 2003; Gholamiandehkordi et al., 2006). This toxin type 
produces of the major toxins only alpha toxin. Since the ban on supplementing growth-
promoting antibiotics in animal feed in the European Union, C. perfringens induced necrotic 
enteritis and related sub-clinical disease have become economically significant problems in 
the broiler industry (Grave et al., 2004; Van Immerseel et al., 2004; Williams, 2005). Despite 
the clinical and economic importance of necrotic enteritis, the pathogenesis of C. perfringens 
associated disease in poultry is still not fully understood. Development of necrotic enteritis 
depends on the presence of predisposing factors, two of the most important being mucosal 
damage caused by coccidial pathogens and feed containing high protein levels (Kaldhusdal 
and Skjerve, 1996; Williams, 2005; Dahiya et al., 2006). These predisposing factors are 
thought to trigger the proliferation of C. perfringens to high numbers in the small intestine, 
leading to intestinal necrosis due to the production of toxins.  
The alpha toxin, the major toxin involved in the pathogenesis of human gas gangrene, has for 
years been considered as the major virulence factor involved in necrotic enteritis in chickens 
(Al-sheikhly and Truscott, 1977; Fukata et al., 1988; Hofshagen, and Stenwig, 1992). 
However, recent studies indicate that alpha toxin is not an essential virulence factor in the 
induction of necrotic enteritis. An alpha toxin knock-out mutant of C. perfringens could cause 
necrotic enteritis in broilers, and the number and severity of lesions were similar compared to 
the wild-type strain (Keyburn et al., 2006). Additionally, it was shown that strains isolated 
from necrotic enteritis outbreaks did not produce more alpha toxin compared to isolates from 
the gut of clinically healthy broilers (Gholamiandehkordi et al., 2006). To our knowledge, it 
has not been reported in literature whether any C. perfringens strain isolated from any normal, 
clinically healthy chicken gut can induce necrotic enteritis. If not, this is a specific 
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characteristic of those strains that are isolated from necrotic enteritis cases. Moreover, it is not 
described in the literature whether alpha toxin producing isolates from other animal species 
presenting C. perfringens associated enteric disease, such as hemorrhagic enteritis in cattle, 
are able to cause disease in poultry. 
Therefore, in the work described below, C. perfringens isolates from both healthy and 
diseased poultry, and from calf hemorrhagic enteritis cases, producing different 
concentrations of alpha toxin in vitro, were tested for their ability to induce necrotic enteritis 
in broilers.  
2. Materials and methods 
2.1. Strains and vaccines 
C. perfringens strains 7, 8 and 17 were isolated from the normal gut microbiota of healthy 
broiler chickens, while strains 48, 56 and 61 were isolated from the intestine of broiler 
chickens with severe necrotic gut lesions (Gholamiandehkordi et al., 2006). Strain 56 has 
been used to optimize the in vivo necrotic enteritis model (Gholamiandehkordi et al., 2007), 
and this strain was used in the present study as a positive control. A chicken C. perfringens 
strain isolated from a field case of necrotic enteritis and its alpha toxin knock-out mutant 
(EHE-NE18 and EHE-N18-M1) were kindly provided by A. Keyburn, Department of 
Microbiology, Monash University, Australia (Keyburn et al., 2006). Strains 669 and 670 were 
isolates from calf hemorrhagic enteritis cases and were kindly provided by Prof. P. Deprez, 
Department of Internal Medicine and Clinical Biology of Large Animals, Ghent University, 
Belgium.  
Before inoculation of chickens, the bacteria were cultured in Brain Heart Infusion (BHI, 
Oxoid, Basingstoke, England) broth for 24 h at 37 °C.  
The commercial Gumboro vaccine, Nobilis Gumboro D78 (Intervet, Mechelen, Belgium) and 
the anticoccidial vaccine Paracox-5TM (Schering-Plough Animal Health, Brussels, Belgium), 
containing live, attenuated oocysts of Eimeria acervulina (E. acervulina), E. maxima (two 
lines), E. mitis and E. tenella were used in this study. 
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2.2. Toxinotyping by PCR 
The toxin type of the C. perfringens isolates was determined by a multiplex PCR, as 
described by Yoo et al. (1997), while the presence of the enterotoxin and the beta2 toxin 
genes were detected with single PCR reactions (Meer and Songer, 1997; Herholz et al., 1999). 
2.3. Alpha toxin quantification by ELISA 
For detection of alpha toxin in C. perfringens culture supernatant, the Bio-X Alpha Toxin 
Elisa Kit (Bio-X Diagnostics, Jemelle, Belgium) was used according to the instructions of the 
manufacturer. A standard curve was constructed based on two-fold serial dilutions of the 
alpha toxin standard and their corresponding net absorbance values. Based on this standard 
curve, the amount of alpha toxin produced by the isolates was calculated according to Zhang 
et al. (2006). 
2.4. Birds and housing 
Intestinal loop assays were performed in 12 commercial laying hens (Isa Brown Warren) of 
twenty weeks old.  
In vivo necrotic enteritis trials using experimental inoculations were performed with Ross 308 
broiler chickens that were obtained as one-day-old chicks from a commercial hatchery. The 
animals were kept in isolation. All treatment groups were housed in the same room, in cages 
of 1 m², on litter floor. All cages were separated by solid walls to prevent contact between 
birds from different treatment groups. Before each trial, the stables were decontaminated with 
peracetic acid and hydrogen peroxide (Hygiasept® vaporizer climasept, SARL Hygiasept, 
Sevrey, France) and a commercial anticoccidial desinfectant (OO-CIDE, DuPont Animal 
Health Solutions, Wilmington, US). For the first trial two hundred and seventy (270) chickens 
and for the second trial eighty-one (81) chickens were reared, 27 per treatment group. They 
were given ad libitum drinking water and feed. A 23 h/1 h light/darkness program was 
applied. 
The animal experiments were carried out according to the recommendations and following 
approval of the Ethical Committee of the Faculty of Veterinary Medicine, Ghent University. 
Chapter 3.1: Virulence 
55 
2.5. Intestinal loop assay 
Hens were premedicated with 0.05mg/kg buprenorphine hydrochloride (Temgesic, Schering-
Plough, New Jersey, US) and 0.05 mg/kg atropine intramuscularly. The chickens were 
anaesthetized using mask induction with isoflurane (Schering-Plough) in 100% oxygen. 
Following intubation with a 3.0 uncuffed tracheal tube (Hudson RCI, Temecula, California, 
USA), a continuous oxygen flow of 1.5-2.0 l/min was administered carrying 1.5-3% of 
isoflurane, depending on the depth of the anaesthesia required. The birds were covered with a 
sterile surgical blanket and the abdominal surface was plucked. After disinfection of the 
incision area with a polyvidone iodine solution (Braunol, B. Braunol Medical, Prague, Czech 
Republic), the abdomen was opened through a midline incision avoiding the perforation of the 
ventral air sacs, and the jejunum was carefully exposed. Jejunal loops of 1.5-2 cm long were 
ligated using surgical suture (Vicryl 3.0, Johnson-Johnson, New Brunswick, New Jersey, US). 
Sufficient blood supply was ensured to all separate loops.  
In each chicken, 8 loops were created. Six C. perfringens strains (7, 8, 17, 48, 56 and 61) 
isolated from poultry were inoculated in six separate loops and two loops were used as 
controls. The loops were inoculated with 1 ml of an overnight culture of C. perfringens strains 
in BHI (about 4 × 108 cfu/ml) or with BHI (control loops) using a 27-gauge needle. The loops 
were repositioned into the abdomen, and the abdominal wall was sutured. After six, ten or 
24 h the hens were euthanized by intravenous injection of T61 (Intervet, Mechelen, Belgium). 
At necropsy, the mucosa of the intestinal loops was macroscopically examined for lesions and 
samples were taken for histopathology as described below. These experiments were 
conducted in two chickens per time point and repeated twice to verify results. A total of 12 
chickens were used. 
2.6. In vivo necrotic enteritis model 
These trials were performed as described previously (Gholamiandehkordi et al., 2007). In 
short: broilers were fed a wheat/rye (43%/7.5%) based diet, with soybean meal as protein 
source. Gumboro vaccine was given in the drinking water at day 18 in all groups. From day 
19 onwards, the same diet was used with the exception that fishmeal (30%) was used as 
protein source. All groups were challenged orally (three times a day) with approximately 
4 × 108 cfu C. perfringens bacteria at days 19, 20, 21 and 22. At day 20 all birds, except the 
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ones in the control group, were orally inoculated with a 10-fold dose of Paracox-5TM. At days 
23, 24 and 25, nine animals of each group were euthanized by intravenous T61 (Intervet, 
Mechelen, Belgium) injection. Necrotic enteritis lesion scoring and sample collection was 
performed, as described below.  
In a first trial the three isolates from the gut of healthy broiler chickens (7, 8 and 17) were 
compared to the C. perfringens strains isolated from necrotic enteritis cases (48, 56, 61) for 
their ability to induce necrotic lesions in the gut. Two control groups were included: a 
negative control group (not inoculated with C. perfringens, not vaccinated with Paracox) and 
a group only inoculated with a 10-fold dose of Paracox vaccine. A chicken C. perfringens 
strain isolated from a field case of necrotic enteritis and its alpha toxin mutant were also 
included (EHE-NE18 and EHE-NE18-M1). 
In a second trial, the necrotic enteritis inducing ability of C. perfringens strains 669 and 670, 
isolated from bovine enteritis cases, was compared to that of strain 56. 
2.7. Macroscopical lesion scoring 
Intestinal lesions in the small intestine (duodenum to ileum) were scored as previously 
described (Keyburn et al., 2006). Briefly, the scoring was as follows: 0 = no gross lesions; 1 = 
congested intestinal mucosa; 2 = small focal necrosis or ulceration (1-5 foci); 3 = focal 
necrosis or ulceration (6-15 foci); 4 = focal necrosis or ulceration (16 or more foci); 5 = 
patches of necrosis 2-3 cm long; 6 = diffuse necrosis typical of field cases. Lesion scores of 2 
or more were classified as necrotic enteritis positive. 
2.8. Histopathology 
Samples from duodenum, jejunum and ileum were fixed in phosphate buffered formalin for at 
least 24 h, after which they were embedded in paraffin. Sections of 5 µm were cut and stained 
with haematoxylin and eosin.  
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3. Results 
3.1. Toxinotyping by PCR 
All isolates were C. perfringens toxin type A, harboring the alpha toxin gene (cpa) but not 
genes encoding beta, iota or epsilon toxin. Isolate 8 was positive for the enterotoxin gene 
(cpe) and isolate 48 was positive for the gene encoding the beta2 toxin (cpb2) (Table I). 
 
Table I: Description of the characteristics of the C. perfringens isolates used in this study. 
Isolate number Health status of the flock 
of origin 
Toxinotype Alpha toxin production 
(µg/ml) 
7 healthy A 0.20 ± 0.07 
8 healthy A (cpe-positive) 14.24 ± 1.40 
17 healthy A 46.91 ± 3.00 
48 necrotic enteritis A (β2-positive) 39.37 ± 4.21 
56 necrotic enteritis A 19.30 ± 2.71 
61 necrotic enteritis A 5.45 ± 1.39 
EHE-NE18 necrotic enteritis A 17.31 ±1.25 
EHE-NE18-M1a    
669 bovine – hemorrhagic enteritis A 22.81 ± 2.73 
670 bovine – hemorrhagic enteritis A 46.04 ± 3.84 
a: knock-out mutant defective in alpha toxin production derived from strain EHE-NE18, kindly 
provided by Dr. A. Keyburn. 
 
3.2. Alpha toxin quantification by ELISA 
Quantification of the alpha toxin is shown in Table I. Large differences in the production of 
alpha toxin were detected when the isolates were compared, independent of their origin. There 
was a high, moderate and low alpha toxin producer in the group of isolates from healthy 
chickens (7, 8 and 17) and also in the group of isolates from diseased chickens (48, 56 and 
61). The chicken isolate EHE-NE18 produced a moderate amount of alpha toxin and its alpha 
toxin mutant (EHE-NE18-M1) did not produce any alpha toxin. The bovine strain 670 
produced high titers of alpha toxin while the other bovine strain (669) produced a moderate 
amount of alpha toxin. 
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3.3. Intestinal loop assay 
Macroscopically, no gross lesions were observed. Microscopically, in one chicken necrosis 
was induced by clinical isolates 48, 56 and 61 after 10 h of incubation but not by strains 
isolated from healthy chickens. The lesions were villus atrophy and blunting, necrosis of 
villus tips, heterophil infiltration and demarcation line formation (Figure 1). The histological 
sections of the clinical isolates (48, 56 and 61) in the other experiments showed detached 
epithelial cells and eosinophylic amorphic debris in the intestinal lumen but no necrosis of 
villus tips.  
 
 
Figure 1: Necrotic lesions after inoculation of intestinal loops with strain 61 for 10 h, 
typically visible as necrosis of villus tips and tissue with an abundance of dead cells and 
fibrin-like material in the lumen in which large clusters of bacteria are present. A: C. 
perfringens–like bacteria; B: Villi; C: demarcation line, D: cellular debris and fibrin-like 
material. 
3.4. Macroscopical observations in the in vivo trials 
Table II summarizes the number of birds having macroscopic necrotic lesions in all trials. 
These lesions presented as multiple foci, mostly in the jejunum. In trial 1, only the animals 
inoculated with strains originally isolated from necrotic enteritis outbreaks (48, 56, 61, and 
EHE-NE18) developed lesions. The alpha toxin mutant EHE-NE18-M1 induced necrotic 
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enteritis lesions in about the same number of birds as compared with the wild-type strain. No 
animals with lesions were found in the groups inoculated with C. perfringens strains from 
clinically healthy birds (7, 8 and 17). No necrotic enteritis lesions were observed in the 
control groups, i.e. the negative control group and the group only inoculated with a 10-fold 
dose of Paracox. The mean of the lesion scores is also shown in Table II. The mean of the 
lesion scores was lower in the groups infected with strains derived from clinically healthy 
flocks compared to the groups infected with necrotic enteritis outbreak strains.  
In trial 2, no gross lesions were observed in the groups that were inoculated with the bovine 
strains (669 and 670) isolated from calf hemorrhagic enteritis cases, while in the group 
inoculated with the poultry derived strain 56, 55.56% of the animals showed lesions (Table II). 
 
Table II: Number of birds with macroscopic necrotic enteritis lesions on the three sampling 
days in all trials.  
Trial Group Day 23 Day 24 Day 25 Total Total (%) Mean score 
1 negative control 0/9 0/9 0/9 0/27 0 0 
 only coccidia 0/9 0/9 0/9 0/27 0 0,30 
 7h 0/9 0/9 0/9 0/27 0 0,41 
 8h 0/9 0/9 0/9 0/27 0 0,56 
 17h 0/9 0/9 0/9 0/27 0 0,52 
 48ne 2/9 0/9 1/9 3/27 11.11 0,81 
 56ne 1/9 5/9 7/9 13/27 48.15 1,56 
 61ne 4/9 5/9 6/9 15/27 55.56 2,07 
 EHE-NE18ne 2/8 2/8 6/8 10/24 41.67 1,5 
 EHE-NE18-M1a 1/8 3/8 7/8 11/24 45.83 2,21 
2 56ne 4/9 5/9 6/9 15/27 55.56 1,48 
 669b 0/8 0/8 0/8 0/24 0 0,40 
 670b 0/8 0/8 0/8 0/24 0 0,58 
Birds with macroscopic necrotic enteritis lesions are the birds with a lesion score of 2 or above. The 
mean of the scores is also shown. 
h
 C. perfringens isolate from clinically healthy broilers 
ne
 C. perfringens isolate from broilers with necrotic enteritis 
b
 C. perfringens isolate from calf hemorrhagic enteritis, kindly provided by Prof. Dr. P. Deprez 
a
 knock-out mutant defective in alpha toxin production derived from strain EHE-NE18, kindly 
provided by Dr. A. Keyburn. 
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4. Discussion 
C. perfringens strains derived from clinically healthy broilers did not produce necrotic 
enteritis in broilers, even in an experimental model using predisposing factors. In contrast, 
strains isolated from outbreaks of necrotic enteritis did produce necrotic gut lesions in both 
trials performed in this study. To our knowledge, this is the first report describing the inability 
of C. perfringens normal gut microbiota isolates to produce necrotic enteritis in a model 
where the disease is consistently reproduced by virulent strains. These results suggest that 
high numbers of C. perfringens in the gut is not sufficient to induce necrotic enteritis but that 
strains from cases of necrotic enteritis do possess virulence factors required to induce disease 
while C. perfringens strains from healthy chickens lack these virulence factors. Thus, 
comparisons of expressed proteins or genome sequences from necrotic enteritis strains versus 
normal gut microbiota strains should allow identification of virulence factors required for 
induction of necrotic enteritis in broilers.  
The ability to induce necrotic lesions was independent of the ability of C. perfringens to 
produce alpha toxin. Indeed, the four strains that were able to induce lesions (48, 56, 61, and 
EHE-NE18), produce different amounts of alpha toxin (Table I), and similar levels of alpha 
toxin were produced in vitro by the normal gut microbiota isolates. The alpha toxin, the major 
toxin involved in the pathogenesis of human gas gangrene, has for many years been proposed 
as being the major virulence factor in causing necrotic enteritis in chickens (Al-Sheikhly and 
Truscott, 1977; Fukata et al., 1988; Hofshagen and Stenwig, 1992). However, recent studies 
indicate that alpha toxin is not an essential virulence factor of necrotic enteritis. It was shown 
that strains isolated from necrotic enteritis outbreaks do not produce more alpha toxin in vitro 
compared to normal broiler gut microbiota isolates (Gholamiandehkordi et al., 2006). 
Additionally, using a gene knock-out mutant, Keyburn et al. (2006) showed that alpha toxin is 
not essential for pathogenesis. Their C. perfringens wild-type strain and its alpha toxin mutant 
were also included in the present experiment and their data were confirmed. 
A multiple-locus variable-number tandem repeat analysis to investigate the evolution of 
virulence and population structure of C. perfringens has shown that strains isolated from 
different animal species can be closely related (Sawires and Songer, 2006), but this does not 
give information on the phenotypical characteristics of the isolates. In our study, isolates from 
calf hemorrhagic enteritis were not able to induce disease in broilers. Keyburn et al. (2006) 
showed that a human gas gangrene isolate (JIR325) was also not able to induce necrotic 
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enteritis in broilers. It is therefore likely that certain C. perfringens strains engage in host-
specific interactions with the chicken host. Especially cytotoxic effects and induction of 
lesions, but maybe not colonization of the gut itself, could be host-specific. Although more 
studies are needed to definitely prove this hypothesis, our data suggest that C. perfringens 
type A isolates from hemorrhagic enteritis in calves do not cause disease in broilers. It is 
unclear whether these strains could be part of the normal gut microbiota of broilers.  
In conclusion, data were produced in agreement with the hypothesis that isolates from broilers 
with necrotic enteritis are virulent while isolates from healthy chickens are not. In addition it 
was demonstrated that induction of necrotic lesions in the broiler gut is not associated with 
the ability to produce alpha toxin in vitro. Moreover, the results also suggest that the virulence 
of C. perfringens strains is to some extent host specific since two C. perfringens strains 
isolated from calf hemorrhagic enteritis were not able to produce necrotic lesions in chickens. 
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Abstract 
Necrotic enteritis in broiler chickens is associated with Clostridium perfringens type A, 
carrying the NetB toxin. Clostridium perfringens type A is also a member of the normal 
intestinal microbiota of broilers. Clinically healthy chickens carry several different 
Clostridium perfringens clones in their intestine. In flocks suffering from necrotic enteritis, 
however, mostly only one single clone is isolated from the gut of all the diseased animals. 
Selective proliferation of these clinical outbreak strains in the gut and spread within the flock 
seems likely, but an explanation has not yet been given. The hypothesis that necrotic enteritis 
associated Clostridium perfringens strains might suppress the growth of normal microbiota 
Clostridium perfringens strains, was therefore tested. Twenty-six Clostridium perfringens 
strains isolated from healthy broilers and 24 clinical outbreak isolates were evaluated for their 
ability to induce intra-species growth-inhibition in an in vitro setup. A significantly higher 
proportion of the Clostridium perfringens clinical outbreak strains inhibited the growth of 
other Clostridium perfringens strains compared to Clostridium perfringens strains isolated 
from the gut of healthy chickens. It is proposed that, in addition to toxin production, intra-
species growth-inhibition may be a virulence trait that contributes to the ability of certain 
Clostridium perfringens strains to cause necrotic enteritis in broilers. 
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1. Introduction 
Since the ban on growth-promoting antibiotics in animal feed in the European Union, 
Clostridium perfringens associated necrotic enteritis is re-emerging in broilers (Grave et al., 
2004; Van Immerseel et al., 2004; Williams, 2005). Necrotic enteritis in poultry is associated 
with C. perfringens type A, carrying the NetB toxin (Keyburn et al., 2008; Van Immerseel et 
al., 2009). C. perfringens type A is also a member of the normal intestinal microbiota of 
broilers. Strains isolated from healthy broilers, however, do not induce necrotic enteritis in an 
experimental model using predisposing factors, in contrast to strains isolated from outbreaks 
of necrotic enteritis (Timbermont et al., 2009). 
In C. perfringens isolates from healthy birds, a high degree of genetic diversity is found, even 
between isolates from the same animal. In contrast, different isolates from a flock suffering 
from a clinical outbreak are generally of the same pulsed-field gel electrophoresis (PFGE) 
type, regardless of the animal or the part of the intestine from which the strain was isolated 
(Nauerby et al., 2003; Gholamiandehkordi et al., 2006). The reason for the presence of a 
single clone in necrotic enteritis outbreaks is not known. It is speculated that during an 
outbreak, certain C. perfringens strains have a competitive advantage over other 
C. perfringens strains in the broiler gut. 
In the present study, strains isolated from healthy broilers and strains isolated from broilers 
suffering from necrotic enteritis were compared with respect to their capacity of intra-species 
growth-inhibition in an in vitro inhibition assay.  
2. Materals and methods 
2.1. Bacteria 
Fifty C. perfringens type A strains belonging to different genotypes, as analyzed by PFGE, 
were included. Thirty-five strains were isolated from broiler chickens in Belgium: 26 strains 
from clinically healthy broiler chickens and 9 strains from broilers suffering from necrotic 
enteritis (Gholamiandehkordi et al., 2006). Fifteen Danish C. perfringens isolates from 
necrotic enteritis cases were kindly provided by Dr. L. Bjerrum (Nauerby et al., 2003). 
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Strains of C. perfringens were grown on Colombia agar (Oxoid, Basingstoke, UK) containing 
5% defibrinated sheep blood. Plates were incubated at 37 °C in an anaerobic working cabinet 
(invivo2500, Ruskinn Life Sciences, Bridgend, UK), in an atmosphere of 
8%H2:8%CO2:84%N2. Strains were stored at -80 °C in lyophilisation medium (LYM) 
containing 7% glucose, 23% Brain Heart Infusion broth (BHI, Oxoid) and 70% defibrinated 
horse serum (Invitrogen, Merelbeke, Belgium). 
2.2. In vitro growth-inhibition assay 
The 50 C. perfringens strains were used in a checkerboard test for intra-species growth-
inhibition. Each strain was cultured anaerobically in BHI broth for 24 h at 37 °C. The 
overnight cultures were diluted in Phosphate Buffered Saline (PBS) to a density of McFarland 
No. 0.5, and 200 µl of these suspensions were spread with a sterile swab on the whole surface 
of BHI agar plates to obtain a bacterial lawn (12cm × 12cm). A single colony of each 
C. perfringens isolate was transferred with a sterile toothpick to the agar plates seeded with 
the different C. perfringens strains. Absence of growth of the bacterial lawn around a colony 
results in an inhibition zone (Figure 1). After overnight incubation under anaerobic 
conditions, diameters of inhibition zones were measured in mm. The tests were performed in 
triplicate. 
 
     
Figure 1: Result of the radial diffusion assay. A colony of a C. perfringens isolate was 
stabbed through a lawn of another C. perfringens strain and partially through the agar 
beneath. A: No inhibition; B: Clear inhibition zone 
 
Chapter 3.2: Growth-Inhibition 
70 
2.3. Statistical analysis 
The data were analysed with SPSS 16 software using the chi-square test to compare the 
number of strains of the normal microbiota group with the number of strains of the necrotic 
enteritis group that were able to inhibit other strains.  The student’s t-test was used to compare 
the mean inhibition zones of the healthy animal strains and the necrotic enteritis strains. 
Significance was determined at P < 0.05. 
3. Results 
Sixty percent of all tested strains inhibited growth of at least one other strain of C. perfringens 
(i.e., there was a zone of clearing around the stabbed colony). While some strains inhibited 
growth of many other strains, others had a very limited inhibitory spectrum. Fifteen (58%) of 
the 26 healthy animal strains and 4 (17%) of the 24 clinical outbreak strains were not able to 
inhibit the growth of any other strain. In contrast, 46% (11/24) of the clinical outbreak strains 
were able to inhibit more than 90% (more than 45/50) of the other strains while this was only 
the case for 15% (4/26) of the healthy animal strains (Figure 2). The number of strains that 
were able to inhibit any number of other strains was significantly higher for the clinical 
outbreak strains than for the healthy animal strains (P < 0.05). If strains were able to inhibit 
the growth of other C. perfringens strains, they were able to inhibit both healthy animal 
strains and necrotic enteritis outbreak strains. 
In the strains that were able to inhibit, the zones of inhibition varied for the strains from 
healthy broilers between 3 mm and 7 mm and for the necrotic enteritis strains between 
3.5 mm and 5.5 mm. There was no significant difference in the average sizes of the inhibition 
zones: 4.9 mm and 4.3 mm for healthy animal strains and clinical outbreak strains, 
respectively. 
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Figure 2: Percentage of C. perfringens strains secreting intra-species inhibitory substances. 
The percentage of healthy animal strains (grey) and clinical outbreak strains (black) of 
C. perfringens that were able to inhibit a number of C. perfringens strains (N = 50), as 
indicated on the X-axis, is shown. 
4. Discussion 
Intra-species inter-strain growth-inhibition can explain the presence of a single clone of 
C. perfringens in a broiler flock suffering from necrotic enteritis. Our results show that 
inhibition of other C. perfringens strains is a trait that is significantly more developed in 
clinical outbreak strains, compared with healthy animal strains. A minority of healthy animal 
strains were able to inhibit other C. perfringens strains isolated from healthy birds and 
necrotic enteritis strains. In a recent study of Barbara et al. (2008), none of the normal flora 
strains (n = 17) could inhibit the growth of other C. perfringens strains. Also a minority of 
necrotic enteritis outbreak strains did not have the intra-species growth-inhibitory phenotype. 
Possibly in these strains other virulence traits may compensate for the lack of inhibitory 
capacity. Another possible explanation for the lack of in vitro inhibitory phenotype is that 
expression of the gene encoding for the growth-inhibiting phenomenon can be down-
regulated by certain signal transduction systems or regulators (Dupuy and Mamouros, 2006). 
The gene for the growth-inhibiting factor might also be located on a plasmid and the absence 
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of growth-inhibition may be caused by the loss of this plasmid after in vitro cultivation (Rood 
and Cole, 1991). 
The results of the radial diffusion assay suggest that the intra-species inter-strain growth-
inhibition is caused by a substance secreted by the bacterium into its micro-environment. The 
nature of this substance is hitherto unclear. It is known that C. perfringens is able to produce 
bacteriocins capable of lysing other C. perfringens strains. Watson et al. (1982) observed that 
79% of strains implicated in food poisoning outbreaks produced bacteriocins; however, only 
18% of 322 isolates from the feces of healthy persons, human and animal infections, various 
foods, and the environment produced bacteriocins suggesting a relationship between 
bacteriocin production and the ability to cause food poisoning. 
In this study, secretion of intra-species growth-inhibitory substances by C. perfringens is 
proposed to be an additional virulence trait that can possibly contribute to the pathogenesis of 
necrotic enteritis by selective proliferation of one single clone in the broiler gut. Indeed, when 
certain environmental predisposing factors, such as a coccidial infection, are present, nutrients 
utilizable by C. perfringens are leaking in the lumen (Collier et al., 2008). Intra-species inter-
strain growth-inhibition may constitute an important advantage for certain strains in the 
competition for nutrients in the intestinal tract. It is well documented that C. perfringens 
requires at least 11 different essential amino acids for its multiplication (Petit et al., 1999). 
Suppressing its competitors may allow unlimited access to the nutrients and thus the 
possibility of explosive multiplication. The massive production of specific toxins and 
enzymes, such as the NetB toxin and proteolytic enzymes (Olkowski et al., 2006; Olkowski et 
al., 2008; Keyburn et al., 2008) at sites of multiplication of these bacteria in the gut would 
then lead to necrotic lesions, and thus the release of more nutrients, completing the cycle.  
In conclusion, C. perfringens outbreak isolates are significantly more capable of intra-species 
growth-inhibition compared to strains isolated from healthy birds. It is proposed that intra-
species growth-inhibition by C. perfringens is a possible virulence trait in necrotic enteritis in 
broilers. 
 
 
Chapter 3.2: Growth-Inhibition 
73 
Acknowledgements 
We would like to thank Veerle Flama for her skilful technical assistance. Dr. L. Bjerrum is 
acknowledged for providing strains. This work was supported by the Institute for Science and 
Technology, Flanders (IWT). F. Van Immerseel is supported by a Postdoctoral Research 
Grant of the Research Foundation - Flanders (FWO) and by the Research Fund of Ghent 
University (BOF). 
Chapter 3.2: Growth-Inhibition 
74 
References 
Barbara A.J., Trinh H.T., Glock R.D., Songer J.G. (2008). Necrotic enteritis-producing strains 
of Clostridium perfringens displace non-necrotic enteritis strains from the gut of chicks. Vet. 
Microbiol. 126, 377-382. 
Dupuy B., Matamouros S. (2006). Regulation of toxin and bacteriocin synthesis in 
Clostridium species by a new subgroup of RNA polymerase σ-factors. Res. Microbiol. 157, 
201-205. 
Collier C.T., Hofacre C.L., Payne A.M., Anderson D.B., Kaiser P., Mackie R.I., Gaskins H.R. 
(2008). Coccidia-inuced mucogenesis promotes the onset of necrotic enteritis by supporting 
Clostridium perfringens growth. Vet. Immunol. Immunopathol. 122, 105-114. 
Gholamiandehkordi A.R., Ducatelle R., Heyndrickx M., Haesebrouck F., Van Immerseel F. 
(2006). Molecular and phenotypical characterization of Clostridium perfringens isolates from 
poultry flocks with different disease status. Vet. Microbiol. 113, 143-152. 
Grave K., Kaldhusdal M.C., Kruse H., Harr L.M., Flatlandsmo K. (2004). What has happened 
in Norway after the ban of avoparcin? Consumption of antimicrobials by poultry. Prev. Vet. 
Med. 62, 59-72. 
Keyburn A.L., Boyce J.D., Vaz P., Bannam T.L., Ford M.E., Parker D., Di Rubbo A., Rood 
J.I., Moore R.J. (2008). NetB, a new toxin that is associated with avian necrotic enteritis 
caused by Clostridium perfringens. PLoS Pathog. 4(2): e26. doi:10.1371/journal.ppat. 
0040026. 
Nauerby B., Pedersen K., Madsen M. (2003). Analysis by pulsed-field gel electrophoresis of 
the genetic diversity among Clostridium perfringens isolates from chickens. Vet. Microbiol. 
94, 257-266. 
Olkowski A.A., Wojnarowicz C., Chirino-Trejo M., Drew M.D. (2006). Responses of broiler 
chickens orally challenged with Clostridium perfringens isolated from field cases of necrotic 
enteritis. Res. Vet. Sci. 8, 99-108. 
Chapter 3.2: Growth-Inhibition 
75 
Olkowski A.A., Wojnarowicz C., Chirino-Trejo M., Laarveld B., Sawicki G. (2008). Sub-
clinical necrotic enteritis in broiler chickens: Novel etiological consideration based on ultra-
structural and molecular changes in the intestinal tissue. Res. Vet. Sci. 85, 543-553. 
Petit L., Gibert M., Popoff M.R. (1999). Clostridium perfringens: toxinotypes and genotype. 
Trends in Microbiol. 7, 104-110. 
Rood J.I., Cole S.T. (1991). Molecular genetics and pathogenesis of Clostridium perfringens. 
Microbiol. rev. 55, 621-648. 
Timbermont L., Lanckriet A., Gholamiandehkordi A.R., Pasmans F., Martel A., Haesebrouck 
F., Ducatelle R., Van Immerseel F. (2009). Origin of Clostridium perfringens isolates 
determines the ability to induce necrotic enteritis in broilers. Comp. Immunol. Microbiol. 
Infect. Dis. 32, 503-512. 
Van Immerseel F., De Buck J., Pasmans F., Huyghebaert G., Haesebrouck F., Ducatelle R. 
(2004). Clostridium perfringens in poultry: an emerging threat for animal and public health. 
Avian Pathol. 33, 537-549. 
Van Immerseel F., Rood J.I., Moore R.J., Titball R.W. (2009). Rethinking our understanding 
of the pathogenesis of necrotic enteritis in chickens. Trends Microbiol. 17, 32-36. 
Watson G.N., Stringer M.F., Gilbert R.J., Mahony D.E. (1982). The potential of bacteriocin 
typing in the study of Clostridium perfringens food poisoning. J. Clin. Pathol. 35, 1361-1365. 
Williams R.B. (2005). Intercurrent coccidiosis and necrotic enteritis of chickens: rational, 
integrated disease management by maintenance of gut integrity. Avian Pathol. 34, 159-180. 
 
  
  
Chapter 3.3: 
Purification and partial 
characterization of a novel 
antimicrobial peptide from Clostridium 
perfringens strain 56 
 
 
 
 
Leen Timbermont§, Lina De Smet‡, Anouk Lanckriet§, Gonzalez Van 
Driessche‡, Freddy Haesebrouck§, Richard Ducatelle§, Bart Devreese‡, Filip 
Van Immerseel§ 
 
 
 
§ Department of Pathology, Bacteriology and Poultry Diseases, Research Group Veterinary 
Public Health and Zoonoses, Faculty of Veterinary Medicine, Ghent University, Salisburylaan 
133, B-9820 Merelbeke, Belgium. 
 
‡ Department of Biochemistry, Physiology and Microbiology, Faculty of Sciences, Ghent 
University, K. L. Ledeganckstraat 35, 9000 Gent, Belgium. 
 
  
Chapter 3.3: Purification and characterization 
79 
Abstract 
Necrotic enteritis in broiler chickens is associated with Clostridium perfringens type A. 
Single strain dominance is found in the gut of broiler chickens suffering from necrotic 
enteritis: within an outbreak, all affected animals carry the same clonal 
Clostridium perfringens strain in the affected tissue. It is known that Clostridium perfringens 
is capable of secreting factors inhibiting growth of other Clostridium perfringens strains and 
this characteristic is more prevalent in outbreak strains compared to normal microbiota 
strains. This characteristic could lead to extensive and selective presence of a strain that 
contains the genetic make-up enabling to secrete toxins that cause gut lesions. This report 
describes the purification and the characterization of a bacteriocin-like inhibitory substance 
(BLIS) from a necrotic enteritis associated Clostridium perfringens strain exhibiting 
antibacterial activity against other Clostridium perfringens strains. Amino acid sequence 
analysis indicated that the BLIS is an 11.5 kDa fragment of a 22 kDa protein and that it 
constitutes the C-terminal part of this protein. The 22 kDa protein is a cytoplasmic membrane 
protein without signal peptide. The antibacterial activity of the purified BLIS was abolished 
by proteolytic enzymes trypsin and proteinase K and by heat treatment (10 min at 80 °C). The 
purified BLIS showed inhibitory activity over a wide pH-range (4.0 to 10.0). Since the 
antibacterial activity against other Clostridium perfringens strains of the purified BLIS had a 
narrower spectrum than the crude supernatant of the secreting strain, most probably different 
of these bacteriocins are produced. 
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1. Introduction 
Clostridium perfringens type A is widely prevalent in the environment and in the intestinal 
tract of animals and men. Necrotic enteritis in poultry is associated with a specific 
subpopulation of C. perfringens type A, i.e. those carrying the NetB toxin (Keyburn et al., 
2008; Van Immerseel et al., 2009). As a consequence, strains isolated from outbreaks of 
necrotic enteritis are able to induce necrotic enteritis in an experimental model using 
predisposing factors, in contrast to strains isolated from the gut of healthy broilers 
(Timbermont et al., 2009a). In C. perfringens isolates from healthy birds, a high degree of 
genetic diversity is found, even between isolates within the gut of a single animal. In contrast, 
in a flock suffering from a clinical outbreak, different isolates are generally of the same 
pulsed-field gel electrophoresis (PFGE) type, regardless of which animal in the flock or which 
part of the intestine the strain was isolated from (Nauerby et al., 2003; Gholamiandehkordi et 
al., 2006). Recent data show that C. perfringens is capable of secreting factors inhibiting 
growth of other C. perfringens strains. The intra-species inhibitory phenotype was shown to 
be more prevalent in outbreak strains compared to normal microbiota strains (Barbara et al., 
2008; Timbermont et al., 2009b). This characteristic could lead to extensive and selective 
presence of a single strain in the gut, and if it contains the genetic make-up enabling to secrete 
toxins, it could consequently cause gut lesions. 
It is known that many C. perfringens strains are able to produce antibacterial proteins, called 
bacteriocins (Tagg et al., 1976). Bacteriocins are proteinaceous toxic compounds produced by 
bacteria that generally inhibit the growth of closely related strains (Jack et al., 1995), and are 
thus potential candidates involved in the intra-species inhibitory phenotype of C. perfringens. 
The nature of the inhibitory component that causes intra-species growth-inhibition in broiler 
outbreak strains was hitherto unknown. Therefore, in the present study, the purification and 
partial characterization of a novel antimicrobial peptide from a C. perfringens outbreak strain 
is described. 
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2. Materials and methods 
2.1. Strains 
Fifty C. perfringens type A strains belonging to different genotypes, as analyzed by PFGE, 
were included. Thirty-five strains were isolated from broiler chickens in Belgium: 26 strains 
from clinically healthy broiler chickens and 9 strains from broilers suffering from necrotic 
enteritis. Fifteen Danish C. perfringens isolates from necrotic enteritis cases were kindly 
provided by Dr. L. Bjerrum (Nauerby et al., 2003; Gholamiandehkordi et al., 2006; 
Timbermont et al., 2009b). Strain 56 was isolated from the intestine of a broiler chicken with 
severe necrotic gut lesions. It was selected from the strains because it is shown to be a virulent 
strain (Timbermont et al., 2009a) and inhibits the growth of 41 of the 50 strains included 
(Timbermont et al., 2009b). C. perfringens strain 6 was isolated from the normal gut 
microbiota of a healthy broiler chicken and was used as indicator strain because it is not able 
to inhibit other C. perfringens strains and its growth is inhibited by strain 56 (Timbermont et 
al., 2009b). 
2.2. Agar spot test 
For the agar spot test, 20 µl drops of the fractions to be tested were spotted on the lawns of 
bacteria. Lawns were prepared by resuspension of colonies in PBS to a density of McFarland 
1, and 100 µl of these suspensions were spread with a sterile swab on the surface of agar 
plates. 
2.3. Antimicrobial protein purification and identification 
C. perfringens strain 56 was grown in Tryptic Soy Broth (TSB, Oxoid, Basingstoke, England) 
for 24 h at 42 °C (500ml). Culture supernatant was obtained by centrifugation at 17000 g for 
15 min at 4 °C. The supernatant was filter sterilized (0.22 µm) and supernatant proteins 
precipitated by overnight incubation in 50% (w/v) (NH4)2SO4 at 4 °C followed by 
centrifugation at 17000 g for 2 h at 4 °C. The precipitate was resuspended in 5 ml of 
phosphate buffered saline (PBS) and dialysed against 10 mM Tris-HCl buffer, pH 8.5 for 24 h 
at 4 °C. This concentrated supernatant was loaded onto a SP-sepharose cation exchange 
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column in 10 mM NaOAc buffer, pH 4. Proteins were eluted stepwise from the column, with 
increasing concentrations of NaCl (up to 1 M). To determine the antimicrobial activity of the 
fractions, two-fold dilutions of the fractions were spotted on a lawn of strain 6 in the agar spot 
test. The most active fractions in the antimicrobial assay were pooled and loaded onto a butyl-
sepharose hydrophobic interaction column in 50 mM Sodium phosphate buffer with 1 M 
(NH4)2SO4, pH 7.4. Proteins were stepwise eluted from the column, with decreasing 
concentrations of (NH4)2SO4. Again, the activity of the fractions was determined and the most 
active fraction was concentrated and analyzed by SDS-PAGE. Precision Plus Protein 
Standard, All Blue (Bio-Rad Laboratories, Hercules, USA) was used as protein marker. The 
protein band was cut from the gel and subjected to in-gel protein digestion with trypsin 
(Devreese et al., 2002) followed by mass spectrometric characterization. After mixing of 1 µl 
of the digestion mixture with 10 µl a-cyano siniapinic acid (5 mg/ml), one microliter was 
spotted onto the target plate and analyzed with the 4800 plus MALDI TOF/TOF Analyzer 
(Applied Biosystems, Foster City, CA). A NCBI BLAST-search was done with the obtained 
amino acid sequences (http://blast.ncbi.nlm.nih.gov/Blast/). The protein fragment sequences 
were also compared with the incomplete EHE-NE18 sequence, kindly provided by Prof. J. 
Rood (Monash University). Prediction of transmembrane helices was done with TMHMM 
(Krogh et al, 2001).  
2.4. Characterization of the antimicrobial peptide 
Thermal, pH and protease stability of the purified bacteriocin-like inhibitory substance (BLIS) 
was tested. The remaining antibacterial activity after treatment was determined by the agar 
spot test and compared with the activity of a corresponding control. Dilutions of treated and 
untreated (control) BLIS were spotted on lawns of strain 6. First, thermal stability of the 
growth-inhibiting factor was investigated by determination of the residual antibacterial 
activity after incubation at 4, 24, 37, 42, 60, 80 and 100 °C for 10, 30 and 60 min. To evaluate 
the influence of pH on activity, the BLIS sample was adjusted to a pH of 2.0, 4.0, 6.0, 8.0, 
10.0 and 12.0 with HCl or NaOH, mixed, incubated at room temperature for 1 h, neutralized 
to pH 7, and tested for activity. Effect of trypsin and proteinase K on bacteriocin activity was 
tested. Each enzyme was prepared at a concentration of 10 mg/ml and added to the purified 
BLIS at a final concentration of 1 and 0.1 mg/ml. After incubation for 1 h at 37 °C, inhibitory 
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activity was tested. The spectrum of the purified BLIS was analyzed by the agar spot test by 
spotting 20 µl drops on lawns of the 50 C. perfringens strains. 
3. Results 
3.1. Purification and identification of the antimicrobial 
peptide produced by Clostridium perfringens strain 56 
The molecular mass of the purified BLIS was approximately 12 kDa, according to SDS-
PAGE (Figure 1). 
50 kDa
37 kDa
25 kDa
20 kDa
15 kDa
10 kDa
M
 
Figure 1: SDS-PAGE analysis of purified BLIS from C. perfringens strain 56 
 
Mass spectrometry of this band identified five protein fragment sequences (Table I). No 
corresponding protein sequence was found in NCBI BLAST 
(http://blast.ncbi.nlm.nih.gov/Blast/). A search in the incomplete EHE-NE18 sequence 
showed identical amino acid sequences in a 22,91 kDa protein (207AA) (Table I). The 
hypothetical protein has no signal sequence and is a basic protein with a pI of 10.36. Analysis 
of the amino acid sequence showed that the protein was composed of 4 transmembrane 
helices (Figure 2). All amino acid sequences found were situated in the last 106 amino acids 
of the protein. They all start after a trypsin cleavage site except for the one starting at amino 
acid 101 (Table I). 
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Table I: Amino acid sequences found by mass spectrometry and their start position in the 
22 kDa protein 
Sequence Start position 
YPYNSTSNVKR AA101 
KSLSEWTWTSLLAGFNA AA130 
TGAFLGALTALYGYGVNT AA149 
NLSVPLTAANA AA167 
ASGLTLSYTYVLQQTTNLGSFENTR AA178 
 
 
Figure 2: Protein profile analysis of the 22 kDa protein 
3.2. Characterization of the antimicrobial peptide 
After 30 min at 80 °C and after 10 min at 100 °C, no antimicrobial activity against strain 6 
was present anymore. Antimicrobial activity was most stable at neutral pH and decrease was 
detected at pH 2 and pH 12. Complete inactivation or significant reduction in antimicrobial 
activity was observed after treatment with trypsin and proteinase K (Table II). The purified 
antimicrobial peptide was able to inhibit the growth of 15 of the 50 C. perfringens strains. It 
did not inhibit the growth of the producer strain, strain 56. 
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Table II: Residual activity of the purified BLIS after incubation at different temperatures for 
10, 30 and 60 minutes, at different pH-values ranging from pH 2 to 12, and after addition of 
trypsin and proteinase K at 0.1 and 10 mg/ml compared to the corresponding control.  
 
Treatment Residual activity compared to 
the corresponding control (%) 
Temperature  
   4 °C; 10 min – 30 min – 60 min 100 
   24 °C; 10 min – 30 min – 60 min (control) 100 
   37 °C; 10 min – 30 min – 60 min 100 
   42 °C; 10 min – 30 min – 60 min 100 
   60 °C; 10 min – 30 min – 60 min 100 
   80 °C; 10 min 25 
   80 °C; 30 min – 60 min 0 
   100 °C; 10 min – 30 min – 60 min 0 
pH  
   2 25 
   4 50 
   6 75 
   7 (control) 100 
   8 75 
   10 50 
   12 25 
Enzymes  
   0 mg/ml (control) 100 
   Trypsin, 0,1 mg/ml 25 
   Trypsin, 1 mg/ml 0 
   Proteinase K, 0,1 mg/ml 0 
   Proteinase K, 1 mg/ml 0 
 
Chapter 3.3: Purification and characterization 
86 
4. Discussion 
Bacteriocin production might be involved in the pathogenesis of necrotic enteritis, since in 
outbreaks of necrotic enteritis single clone dominance is found (Nauerby et al., 2003; 
Gholamiandehkordi et al., 2006) and intra-species inter-strain growth-inhibition was found to 
be more prevalent in outbreak strains from broilers compared to normal microbiota strains 
(Barbara et al., 2008; Timbermont et al., 2009b). 
The antibacterial peptide identified in this study is a novel peptide without any homology with 
currently known bacteriocins or antimicrobial proteins. No sequence similarity was found 
with any genes or proteins in database searches. Even more, no similarity was found with 
gene or protein sequences of any of the 3 genome sequenced C. perfringens type A strains 
(Shimizu et al., 2002; Myers et al., 2006). The sequenced strains are a gangrene strain and a 
food poisoning strain isolated from humans and a gangrene strain isolated from soil. The 
antimicrobial peptide may be specific for animal and even for broiler necrotic enteritis strains, 
since a match was found in the sequence of EHE-NE18, a strain isolated from a chicken 
suffering from necrotic enteritis (Keyburn et al., 2008). 
The newly identified bacteriocin-like peptide is hypothesized to be released by proteolytic 
activity from a 22 kDa protein without signal peptide that is located in the cytoplasmic 
membrane. The amino acid sequence of the protein indicates the presence of four 
transmembrane helices. An extracellular loop is located between the third and the fourth 
transmembrane helix (Figure 2). Protease activity may cleave the protein at this position, 
releasing a 12 kDa protein fragment extracellullarly. All amino acid sequences found by mass 
spectrometry, were situated in the last 106 amino acids of the 22 kDa protein. Remarkably, all 
amino acid sequences started after a trypsin cleavage site except the one starting at amino acid 
101 (Y101; Table I). This result suggests that the purified fragment starts at Y101 since an in-
gel trypsin digestion was performed before mass spectrometry. A fragment starting at Y101 
would have a molecular mass of 11,538 kDa which is in accordance with the estimated 
molecular mass of the purified antimicrobial peptide (Figure 1). The extracellular loop starts 
around amino acid at position 100 and a cleavage site of proteinase K is located before Y101. 
Bacteriocins from Gram-positive bacteria are usually produced as precursors with N-terminal 
signal peptides (Jack et al., 1995). The signal peptides serve as recognition signals for the 
export of the bacteriocins out of the cells, and they also protect the producers against their 
own bacteriocin by making them biologically inactive inside the cell. Concomitant with the 
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export from the cell, bacteriocins and antimicrobial peptides are processed and activated. 
However, it has been shown that antimicrobial peptides can be produced from the degradation 
of larger proteins. For example, Faye et al. (2002) showed that Propionibacterium jensenii 
secretes an inactive proprotein which is proteolytically activated in the environment. To our 
knowledge, this is the first description of a bacteriocin-like peptide that may be formed by an 
external protease from a bacterial putative cytoplasm membrane associated protein. 
The transmembrane helix at the C-terminal part of the 12 kDa part of the protein, might 
suggest that the antimicrobial peptide acts by pore formation. This is a feature similar to those 
of many characterized antimicrobial peptides from Gram-positive bacteria (Jack et al., 1995). 
It has indeed been shown that the C-terminal region of class IIa bacteriocins forms one or two 
helices and they penetrate the cell membrane, thereby inducing leakage and cell death (Moll 
et al., 2000; Morisset et al., 2004). 
The C. perfringens strain 56 most likely secretes or produces more bacteriocins in addition to 
the protein identified in this work. Indeed, the inhibitory spectrum of C. perfringens strain 56 
and that of the purified BLIS are not identical. It is not unusual that a C. perfringens strain 
produces more than 1 bacteriocin simultaneously. As an example, Higa et al. (1991) showed 
that C. perfringens SN-17 produced two bacteriocins in succession. Moreover, it was also 
shown that these bacteriocins have different inhibitory spectra.  To detect the other 
antimicrobial factor(s), screening of the protein fractions derived from the supernatant must 
be done using other indicator strains. C. perfringens strain 56 is not sensitive to its own 
bacteriocin. Genes encoding membrane-associated molecules that confer a degree of specific 
protection upon the producer strain have been found. For example, Diep et al. (2007) showed 
that an immunity protein prevents Lactococcus lactis from being killed by its permeabilizing 
peptide-bacteriocin, lactococcin A, by formation of a strong complex with the receptor 
proteins and the bacteriocin. Moreover, it was shown that the immunity protein is only 
expressed if mature bacteriocin is produced or if it is present in the environment (Diep et al., 
2007). 
In conclusion, a new antimicrobial peptide derived from a necrotic enteritis inducing 
C. perfringens strain was purified and partly characterized. Further studies are necessary to 
determine the mode of action and the target of the bacteriocin-like peptide and to elucidate its 
role in the pathogenesis of necrotic enteritis. 
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Chapter 4: 
General Discussion 
1. Virulent and avirulent Clostridium perfringens 
strains 
For over 30 years, it was believed that alpha toxin was the key virulence factor in necrotic 
enteritis in broiler chickens caused by C. perfringens. As a consequence, it seemed logical 
that, given appropriate conditions in the chicken intestinal tract, all strains of C. perfringens 
were able to produce necrotic enteritis lesions. However, using a gene knock-out mutant it 
was shown that alpha toxin is not essential for virulence (Keyburn et al., 2006). Moreover, it 
is now known that only specific strains are able to produce necrotic enteritis in broilers, i.e. 
those strains that are isolated from outbreaks of the disease (Chapter 3.1). Chicken normal 
microbiota strains or strains from enteric disease in other species are not virulent for broiler 
chickens in an experimental infection model. Thus not only predisposing factors are necessary 
to induce necrotic enteritis, but the genetic make-up of the strain is also a crucial factor. 
Therefore, key virulence determinants specific for necrotic enteritis outbreak isolates were 
searched by researchers in the last few years. 
1.1. Not alpha toxin but NetB is important for virulence 
Recently, a novel toxin has been described that is associated with necrotic enteritis in broilers 
(Keyburn et al., 2008). The toxin has amino acid sequence similarity to beta toxin from 
C. perfringens (38% amino acid sequence identity) and therefore, it is called NetB (Necrotic 
Enteritis Toxin B-like). The toxin was identified using two complementary approaches. The 
supernatant of C. perfringens cultures was screened in vitro for proteins that were cytotoxic 
for a chicken leghorn male hepatoma cell line (LMH) and the netB structural gene was 
identified by sequencing the genome of a necrotic enteritis outbreak isolate and by comparing 
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the genome of the necrotic enteritis isolate with the known genomes of other Clostridia. Both 
native and recombinant NetB caused cell rounding and lysis of LMH cells, and it was shown 
that small hydrophilic 1.6 - 1.8nm pores were formed. Moreover, a netB mutant of 
C. perfringens failed to cause necrotic lesions in the gut of experimentally infected broilers, 
but a mutant complemented with the wild-type netB gene was as virulent as the wild-type 
strain (Keyburn et al., 2008). Confirmation for the role of NetB in disease came from the 
finding that most necrotic enteritis outbreak strains carry the netB gene, whereas non-necrotic 
enteritis derived C. perfringens isolates lack this gene (Keyburn et al., 2008). Several groups 
screened C. perfringens isolates derived from different countries for the occurrence of netB. 
In a Canadian study, 95% (39/41) C. perfringens isolates from broilers with necrotic enteritis 
were positive for netB while only 35% (7/20) isolates from healthy boilers were netB positive 
(Chalmers et al., 2008). A screening of isolates from the US reported a carriage rate of 58% 
(7/12) for the necrotic enteritis isolates while only 8.75% (7/80) normal microbiota strains 
carried the netB gene (Martin and Smyth, 2009). The isolates used in Chapter 3.2 were also 
screened. Of the 26 isolates from healthy broilers from Belgium, only 1 (3.8%) was netB 
positive while 20 of the 24 (83%) Belgian and Danish necrotic enteritis isolates were netB 
positive (unpublished data). This is in accordance with NetB being important for necrotic 
enteritis. However, all these studies have also found some isolates from diseased birds that do 
not carry the netB gene. A plausible explanation is that these isolates may possess a sequence 
divergent of the published toxin gene sequence. Another possibility is that the toxin gene is 
lost during culture. Such possible instability of the virulent phenotype might occur if the netB 
gene is on a plasmid that is readily lost during the colony purification process. Loss of 
virulence following in vitro culture is not an uncommon occurrence in pathogenic bacteria. 
Also the isolation protocol is an important issue here. Clostridium perfringens strains are 
always present in the gut of animals and isolation of strains should be performed with care, 
preferentially within the lesions, to ensure picking the causal strains.  
To determine if netB is essential for virulence, it is important to determine the disease 
producing capability of both netB positive strains recovered from healthy chickens, and netB 
negative strains recovered from chickens suffering from necrotic enteritis. In Chapter 3.1, 
strain 56 and strain 61 were able to induce necrotic enteritis lesions in 48.15% and 55.56% of 
infected chickens, respectively. They both carry the netB gene. Strain 48 was able to induce 
disease in 11.11% of the animals while it is a netB negative strain. However, the genotype of 
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the isolates recovered from lesions was not compared with the genotype of the test strain. 
Therefore, it can not be ruled out that the small amount of lesions is caused by an 
environmentally derived organism, especially since the chickens in this experimental model 
are exposed to a lot of predisposing factors (Gholamiandehkordi et al., 2007) and are thus 
more prone to developing necrotic enteritis. Strain 23, the only netB positive strain isolated 
from healthy broilers used in Chapter 3.2 was tested in our in vivo model and it was able to 
induce lesions in 36% infected broiler chickens. Moreover, a necrotic enteritis isolate without 
the netB gene and a C. perfringens isolate from a healthy broiler with the netB gene but with a 
premature stop codon were also tested in our in vivo model. Both strains were unable to 
induce necrotic enteritis lesions in the infected animals (own unpublished data). These results 
support the hypothesis that NetB plays a central role in necrotic enteritis. A recent 
unpublished study, using a large number of NetB positive and negative C. perfringens strains 
to inoculate broiler chickens, showed a perfect match between necrotic enteritis induction and 
the ability to produce NetB (Keyburn et al., personal communication). 
1.2. Growth-inhibition 
1.2.1. Bacteriocin or antibiotic? 
The peptide identified in Chapter 3.3 is a bacteriocin and not an antibiotic. Indeed, 
bacteriocins are often confused in the literature with antibiotics. All classes of bacteriocins are 
ribosomally synthesized and are encoded by one structural gene. Only class I bacteriocins, the 
lantibiotics, are post-translationally modified to produce the active form. In contrast, 
antibiotics are generally considered secondary metabolites and they are not ribosomally 
synthesized. Antibiotics may be composed of amino acids but they are enzymatically 
synthesized. Peptide antimicrobials are nonribosomally synthesized by the multiple-carrier 
thiotemplate mechanism. In this template-driven assembly, peptide synthetases assemble 
amino acids to form the antibiotic molecule (Hancock and Chapple, 1999). Generally, 
antibiotics are considered to have a wide spectrum while most bacteriocins have a narrow 
spectrum by killing closely related bacteria. Also the mode of action distinguishes 
bacteriocins from antibiotics. Bacteriocins act mostly by pore formation while most 
antibiotics inhibit RNA, DNA or protein synthesis and cell wall synthesis. Antibiotic 
resistance is usually associated with a genetic determinant, facilitating the transfer of 
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resistance between cells, strains and species. Unlike most antibiotic resistance, bacteriocin 
resistance usually results from a physiological change in the target cell membrane (Cleveland 
et al., 2001; Eijsink et al., 2002; Joerger, 2003; Gillor et al., 2008). The main differences 
between bacteriocins and antibiotics are summarized in Table I. 
Based on these differences, it can be concluded that the antimicrobial peptide isolated in 
Chapter 3.3 is a bacteriocin. Indeed, the purified antimicrobial factor is produced by a 
bacterium, it is a peptide, has a narrow spectrum, is not toxic to the producer strain, and 
sequence analysis suggest that the peptide acts by pore formation. Since it is heat labile, it can 
be classified as a class III bacteriocin although it is not a large peptide. 
 
Table I: Bacteriocins versus antibiotics (Adapted from Cleveland et al., 2001) 
Characteristic Bacteriocins Antibiotics 
Producer organism Bacteria Microorganisms including fungi 
and protozoa 
Synthesis Ribosomal Secondary metabolite 
Activity Narrow spectrum Varying spectrum 
Mode of action Mostly pore formation, sometimes 
interference with cell wall biosynthesis 
Cell membrane or intracellular targets 
Interaction requirements Sometimes docking molecules Specific target 
Mechanism of target cell 
resistance or tolerance 
Usually adaptation affecting cell 
membrane composition 
Usually genetically transferable 
determinant affecting different sites 
depending on the mode of action 
 
1.2.2. Significance in pathogenesis 
In natural cases of necrotic enteritis, mostly one clone of C. perfringens is found in the gut of 
the animals while in healthy birds different clones are present (Nauerby et al., 2003; Engström 
et al., 2003; Gholamiandehkordi et al., 2006).  The fact that this single strain dominance is 
described in several studies indicates that it is an essential step in the pathogenesis of necrotic 
enteritis. Moreover, this dominance of one virulent C. perfringens isolate could be reproduced 
in an experimental infection model after administration of a combined inoculum comprising 
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different necrotic enteritis strains or a combination of virulent and avirulent C. perfringens 
strains (Barbara et al., 2008). Finally, the secretion of factors inhibiting growth of other 
C. perfringens strains is shown to be more prevalent in outbreak strains than in normal 
microbiota strains in vitro (Chapter 3.2.; Barbara et al., 2008). Taken together, these results 
suggest that this is a trait associated with virulence. Although there is no information on in 
vivo bacteriocin production by C. perfringens, production of bacteriocins by a virulent strain 
in the gut would allow this strain to displace the C. perfringens strains present. Inhibiting the 
growth of other C. perfringens strains in the gut is also important as part of the competition 
for nutrients. Indeed, C. perfringens is not able to produce 13 amino acids and is thus 
dependent on environmental presence of these molecules.  
It is pertinent to note that there are also examples of other antimicrobial factors of Gram-
positive bacteria that are associated with virulence. In persistent endodontic infections where 
Enterococcus faecalis is dominant, a low number of other species is found. It is therefore 
suggested that AS-48 and other bacteriocincs of E. faecalis, although they are not strictly 
acting as virulence factors, contribute to its dominance in persistent endodontic infections and 
may serve as a means to obtain ecological advantages which can result in disease (Kayaoglu 
and Ørstavik, 2004).  
2. New insights in pathogenesis, a presumed model 
After Keyburn et al. (2006) showed that alpha toxin is not an essential virulence factor in 
necrotic enteritis in broiler chickens, new C. perfringens virulence factors have been proposed 
and new insight was gained into the mechanisms by which Eimeria predispose to Clostridium 
perfringens induced necrotic enteritis.  The current knowledge is summarized in Figure 1. 
In short, Eimeria parasites induce leakage of plasma proteins by killing epithelial cells as a 
consequence of the intracellular stages of their life cycle. Moreover, according to Collier et al. 
(2008), a coccidial infection enhances mucus production in the intestine. Both effects provide 
an increase in available nutrients and create an environment favorable for proliferation of 
C. perfringens. Indeed, C. perfringens lacks the machinery to produce 13 amino acids but is 
able to utilize mucus as a substrate. Finally, Park et al. (2008) suggested that the exacerbated 
pathological findings after co-infection with Eimeria and C. perfringens are caused by an 
altered cytokine response. Taken together, these data show that an Eimeria infection aids in 
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the first stage of pathogenesis: massive proliferation of C. perfringens in the gut. The factors 
involved in the second stage of pathogenesis, possibly are bacteriocins. A significantly higher 
proportion of virulent C. perfringens strains produce bacteriocins compared to normal 
microbiota C. perfringens strains (Chapter 3.2). By inhibiting other C. perfringens strains, 
the virulent strain is able to obtain the maximum benefit of the increased nutrient availability 
due to the Eimeria infection. The virulent strain is thus able to proliferate massively and as a 
consequence it secretes virulence factors playing a role in the final step in pathogenesis: the 
induction of necrotic lesions. Olkowski et al. (2006; 2008) suggested that the initial 
pathological changes are due to the activity of collagenolytic enzymes. The nature of the 
morphological changes seen in the early stages of necrotic enteritis is consistent with the 
action of collagenolytic enzymes. Indeed, the pathological changes start at the basal and 
lateral domains of enterocytes and then invade progressively the entire lamina propria. Both 
host collagenases and collagenolytic enzymes secreted by proliferating pathogens may play a 
role. It was shown that virulent C. perfringens strains are able to secrete collagenolytic 
enzymes and high levels of different collagenolytic enzymes were found in intestinal tissue of 
broilers challenged with C. perfringens, in comparison to controls (Olkowski et al., 2008). 
Furthermore, it is shown that the NetB toxin is crucial for the induction of necrotic enteritis 
(Keyburn et al., 2008). NetB forms pores in a chicken epithelial cell line in vitro. Its activity 
in vivo is not shown yet, but it may induce necrotic lesions by forming pores in enterocytes 
leading to cell death. By inducing necrotic enteritis lesions, more nutrients are leaking into the 
gut lumen which again can be used by C. perfringens strains.  
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Figure 1: Summary of the pathogenesis of C. perfringens induced necrotic enteritis 
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3. Implications: possible improvement of control measures 
Control of necrotic enteritis has commonly been accomplished by administration of 
antimicrobials in feed or water. However, concerns are rising about effects on human health 
of such routine use of antimicrobials because of the emergence of antibiotic resistance. 
Therefore, the European Union banned the use of antibiotics as antimicrobial growth 
promoters in animal production (Van Immerseel et al., 2009). Alternative non-antibiotic 
approaches to control necrotic enteritis are thus searched for. Vaccination is a widely used 
preventive measure against many infectious diseases in mammals and poultry (Dahiya et al., 
2006). Because bacteriocins are commonly found in food and thus have been consumed for 
centuries, they are considered natural and nontoxic to eukaryotic cells, in contrast to 
traditional antibiotics (Cleveland et al., 2001; Lin, 2009). 
3.1. Alpha toxin as vaccine 
Despite the fact that it has been shown that alpha toxin is not essential for the development of 
necrotic enteritis (Keyburn et al., 2006), specific antibodies against alpha toxin protect birds 
from disease. Vaccines using recombinant alpha toxin in toxoid and active form and live 
delivery of the C-terminal (non-toxic) domain of alpha toxin by an attenuated Salmonella 
enterica serovar Typhimurium strain have been tested and shown to give partial protection 
against necrotic enteritis in experimental challenge models (Kulkarni et al., 2007; Zekarias et 
al., 2008; Cooper et al., 2009). Initially, it was not clear how antibodies against alpha toxin 
could offer any level of protection if alpha toxin did not play a part in the pathogenesis. 
However, Zekerias et al. (2008) found that serum antibodies, from broilers that had been 
vaccinated, bound directly to the cell surface of C. perfringens and suppressed its growth in 
vitro. Antibodies binding to the membrane-bound preprotein might block protein transport 
channels and as a consequence, inhibit proliferation of the bacteria (Zekarias et al., 2008). 
Alpha toxin can thus be used as a protective antigen to vaccinate broilers, but this does not 
necessarily mean that alpha toxin plays a primary role in the pathogenesis of necrotic enteritis. 
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3.2. Other antigens as vaccine 
Thompson et al. (2006) have used alpha toxin deficient mutants to immunize broilers orally 
and found that these strains protected birds from experimental necrotic enteritis. These results 
clearly demonstrate that antigens other that alpha toxin can provide immunity against necrotic 
enteritis. Subsequently, Kulkarni et al. (2006) identified six proteins that reacted to serum 
antibodies from birds immune to necrotic enteritis in the supernatant of virulent 
C. perfringens strains and not in the supernatant of avirulent C. perfringens strains. These 
proteins are a hypothetical protein (HP, possibly a zinc-binding protease); pyruvate:ferredoxin 
oxidoreductase (PFOR); Elongation factor G (EF-G); Perfringolysin O; glyceraldehyde-3-
phosphate dehydrogenase (GAPDA) and fructose 1,6-biphosphate aldolase (FBA). 
Recombinant HP, PFOR, GAPDA and FBA were tested as vaccine and all proteins protected 
broiler chickens against a mild challenge while immunization with HP and PFOR also offered 
protection against a severe challenge (Kulkarni et al., 2007). Broilers orally immunized with 
an avirulent Salmonella enterica serovar Typhimurium vaccine vector expressing FBA or HP 
proteins were also significantly protected against challenge (Kulkarni et al., 2008). Also other 
proteins that have been shown to play a role in the pathogenesis of necrotic enteritis might be 
good candidates as vaccine antigens. These include the metalloproteinases that are suggested 
to have a role in early lesion development and the NetB protein (Olkowski et al., 2008; 
Keyburn et al., 2008). Candidate protective antigens have thus been identified. This does not 
mean that a solution to the necrotic enteritis problem is found, but the results are promising 
for an answer in the near future. 
3.3. Gmo probiotics expressing bacteriocins 
The use of bacteriocins active against C. perfringens could also be a good alternative for 
antibiotic control of necrotic enteritis. Bacteriocins of C. perfringens are naturally present in 
the intestine, and can be considered as safe. There are two possible ways to deliver the 
bacteriocins in the intestinal tract: by the administration of bacteriocin-producing bacteria or 
by the administration of purified bacteriocins (Kirkup, 2006). The purified bacteriocins can be 
included in the feed. However, sensitivity of bacteriocins to gastric acidity and the presence of 
proteases in the gastrointestinal tract can potentially result in loss of activity when the 
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bacteriocins are orally administered. An additional difficulty is the challenge of bulk 
production of purified bacteriocins. 
To circumvent the loss of activity, the genes for bacteriocin production can be cloned and 
expressed in an appropriate bacterial carrier. This approach not only prevents in vivo 
degradation of the bacteriocin during gastric transit, but it also facilitates continued 
bacteriocin production at the site of infection. It is important that the bacterial carrier is able to 
colonize the gut and is not pathogenic to the host. Probiotic strains can be used as bacterial 
carrier. Probiotics are ‘live microorganisms, which, when consumed in adequate amounts, 
confer a health benefit on the host’. The potential of genetically modified bacteriocin-
producing bacteria has already been shown. An avian E. coli strain genetically engineered to 
produce the bacteriocin microcin 24 lowered intestinal Salmonella Typhimurium counts in 
chickens when administered continuously in the water supply (Wooley et al., 1999).  
As with any antimicrobial compound, also for bacteriocins it is important to consider the issue 
of resistance. Although the mechanism of action is not known for all bacteriocins, most of the 
bacteriocins appear to interact with the bacterial membrane. Therefore, resistance is usually 
the result of changes in the membrane of bacteria targeted by a bacteriocin (Joerger, 2003). 
However, in the producer strains, bacteriocins are accompanied by specific immunity proteins 
that can theoretically be transferred horizontally to pathogens (Kirkup, 2006).  
If bacteriocins are going to be used as a strategy for the prevention of necrotic enteritis or 
other infectious diseases, there are some important requirements, such as stability, lack of 
toxicity, a specific activity spectrum, lack of development of resistance, and a thorough 
understanding of their biochemical and genetic properties. A detailed knowledge of the 
isolated bacteriocin structures and properties is therefore needed. The same goes for the 
carrier strain.  
4. Conclusion 
The past decade, great progress has been made in understanding broiler necrotic enteritis. It is 
shown that the single strain dominance found in natural cases of necrotic enteritis is likely to 
be due to bacteriocin production by C. perfringens strains. The assumption that alpha toxin 
was the major virulence factor in necrotic enteritis is refuted and a novel toxin, NetB, is now 
associated with necrotic enteritis. Proteolytic enzymes are suggested to have a role in the early 
Chapter 4: General Discussion 
105 
stages of pathogenesis. This insight in the etiology and the pathogenesis of C. perfringens 
infection in the gut provides important information that will be valuable to develop effective 
disease control strategies. 
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Summary 
Necrotic enteritis was first described in 1961. It is a common enteric disease, caused by 
Clostridium perfringens type A. However, C. perfringens type A can also be present in the 
intestine of healthy broilers. Necrotic enteritis is characterized clinically by a sudden increase 
in flock mortality, often without premonitory signs. Also a sub-clinical form of necrotic 
enteritis is described. At necropsy, necrotic foci are found in the small intestinal mucosa. The 
disease usually occurs in broiler chickens at about 4 weeks after hatching and is found in all 
poultry-growing areas of the world. Despite the clinical and economic importance of necrotic 
enteritis, the pathogenesis of C. perfringens associated disease in poultry is still not fully 
understood. For a long time, it was believed that alpha toxin was the key virulence factor in 
necrotic enteritis in broiler chickens caused by C. perfringens but, at the start of this thesis, its 
role in the pathogenesis of necrotic enteritis was called into doubt. 
 
C. perfringens type A is associated with necrotic enteritis but can also be detected in 
relatively high numbers in the intestinal tract of apparently normal chickens. Consequently, in 
the first study of this thesis (Chapter 3.1), the hypothesis was tested that the necrosis 
inducing capability would be a characteristic of specific strains. C. perfringens isolates from 
both clinically healthy broilers and broilers suffering from necrotic enteritis were compared 
for their ability to induce necrotic lesions using an experimental necrotic enteritis model in 
broiler chickens. High, intermediate and low alpha toxin producing strains were chosen from 
each isolation source to determine the role of alpha toxin in the pathogenesis of necrotic 
enteritis. In this experimental model, only the isolates from field outbreaks induced necrotic 
gut lesions, independent of the amount of alpha toxin produced in vitro. It was also shown 
that alpha toxin producing isolates from calf hemorrhagic enteritis cases were not able to 
induce necrotic enteritis in poultry. These results suggest that alpha toxin is not important to 
induce necrotic lesions in broiler chickens. Moreover, the results are indicative of the 
presence of host specific virulence factors in certain C. perfringens strains, isolated from 
chickens with intestinal necrotic enteritis lesions. 
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Clinically healthy chickens carry several different C. perfringens clones in their intestine. In 
flocks suffering from necrotic enteritis, however, mostly only one single clone is isolated 
from the gut of all the diseased animals. Selective proliferation of such clinical outbreak strain 
in the gut and spread within the flock seems likely. The hypothesis that necrotic enteritis 
associated C. perfringens strains might suppress the growth of normal microbiota 
C. perfringens strains, was therefore tested (Chapter 3.2). Twenty-six C. perfringens strains 
isolated from healthy broilers and 24 clinical outbreak isolates were evaluated for their ability 
to induce intra-species growth-inhibition in an in vitro setup. A significantly higher 
proportion of the C. perfringens clinical outbreak strains inhibited the growth of other 
C. perfringens strains compared to C. perfringens strains isolated from the gut of healthy 
chickens. It is proposed that, in addition to toxin production, intra-species growth-inhibition 
may be a virulence trait that contributes to the ability of certain C. perfringens strains to cause 
necrotic enteritis in broilers. The secretion of factors inhibiting the growth of other 
C. perfringens strains could lead to extensive and selective presence of a strain that contains 
the genetic make-up enabling to secrete toxins that cause gut lesions. 
 
In Chapter 3.3, the purification and the characterization of such a growth-inhibiting factor is 
described. A bacteriocin-like inhibitory substance (BLIS) was purified from a necrotic 
enteritis associated C. perfringens strain exhibiting antibacterial activity against other 
C. perfringens strains. Amino acid sequence analysis indicated that the BLIS is an 11.5 kDa 
fragment of a 22 kDa protein and that it constitutes the C-terminal part of this protein. The 
22 kDa protein is a cytoplasmic membrane protein without signal peptide. The antibacterial 
activity of the purified BLIS was abolished by proteolytic enzymes trypsin and proteinase K 
and by heat treatment (10 min at 80 °C). The purified BLIS showed inhibitory activity over a 
wide pH range (4.0 to 10.0). Since the antibacterial activity against other C. perfringens 
strains of the purified BLIS had a narrower spectrum than the crude supernatant of the 
secreting strain, most probably different of these bacteriocins are produced. 
 
In conclusion, this thesis offers new insights in the pathogenesis of C. perfringens necrotic 
enteritis in broiler chickens. It was shown that only a specific subpopulation of C. perfringens 
type A strains are able to induce necrotic enteritis lesions. We suggest that the single clone 
dominance found in necrotic enteritis is due to the secretion of growth-inhibiting factors, also 
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called bacteriocins, secreted by these virulent strains. This provides important information 
that will be valuable to develop effective disease control strategies. 
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Samenvatting 
Necrotische enteritis werd voor het eerst in 1961 beschreven. Het is een vaak voorkomende 
darmziekte veroorzaakt door Clostridium perfringens type A. Hoewel C. perfringens dus in 
staat is om necrotische enteritis te veroorzaken, komt deze bacterie bijna altijd voor in de 
darm van gezonde vleeskippen. Necrotische enteritis wordt klinisch gekarakteriseerd door een 
plotse stijging van sterfte in een toom, meestal zonder voorafgaande tekenen. Er is ook een 
subklinische vorm van necrotische enteritis beschreven. Bij lijkschouwing worden necrotische 
haarden gevonden in de mucosa van de dunne darm. De ziekte komt meestal voor bij 
vleeskippen van ongeveer 4 weken oud en komt voor in alle landen waar pluimvee gefokt 
wordt. Ondanks het klinische en economische belang van necrotische enteritis, is de 
pathogenese nog niet volledig ontrafeld. Lange tijd werd er gedacht dat alfa toxine de 
belangrijkste virulentiefactor was van C. perfringens die een rol speelt in necrotische enteritis. 
Bij het begin van deze thesis werd de rol van alfa toxine in de pathogenese van necrotische 
enteritis echter in twijfel getrokken. 
 
C. perfringens type A wordt geassocieerd met necrotische enteritis maar kan ook in relatief 
hoge aantallen teruggevonden worden in de darm van gezonde vleeskippen. Daarom werd in 
het eerste hoofdstuk van deze thesis (Chapter 3.1), de hypothese getoetst dat necrotische 
enteritis zou veroorzaakt worden door welbepaalde stammen van C. perfringens. Hiervoor 
werden C. perfringens isolaten van zowel klinisch gezonde vleeskippen als van vleeskippen 
met necrotische enteritis getest op hun capaciteit om necrotische letsels te induceren in een 
experimenteel necrotisch enteritis model in vivo. Om de rol van alfa toxine in de pathogenese 
na te gaan werden C. perfringens isolaten uit kippen met necrotische enteritis en isolaten uit 
klinisch gezonde kippen gekozen die in vitro hoge, gemiddelde en lage concentraties alfa 
toxine produceerden. Enkel de isolaten geïsoleerd uit kippen met necrotische enteritis konden 
necrotische letsels induceren, ongeacht de concentratie alfa toxine die ze produceerden in 
vitro. Er werd ook aangetoond dat alfa toxine producerende isolaten van gevallen van 
hemorragische enteritis bij het kalf niet in staat waren om necrotische enteritis in vleeskippen 
te induceren. Deze resultaten suggereren dat alfa toxine niet belangrijk is om necrotische 
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letsels te induceren bij vleeskippen. Bovendien doen deze resultaten vermoeden dat de 
C. perfringens stammen geïsoleerd uit kippen met necrotische letsels, over gastheer specifieke 
virulentiefactoren beschikken. 
 
Klinisch gezonde vleeskippen hebben verschillende C. perfringens klonen in hun darm terwijl 
in een toom die necrotische enteritis doormaakt, meestal één en dezelfde kloon geïsoleerd 
wordt uit de darm van verschillende vleeskippen. Selectieve proliferatie in de darm van één 
stam en verspreiding in de toom lijkt waarschijnlijk. De hypothese dat necrotische enteritis 
geassocieerde C. perfringens stammen de groei van C. perfringens stammen uit de normale 
flora inhiberen, werd daarom getest (Chapter 3.2). Bij 26 C. perfringens isolaten uit 
gezonde vleeskippen en 24 isolaten uit klinische uitbraken werd nagegaan in hoeverre ze over 
de eigenschap beschikken om elkaars groei te inhiberen in vitro. Significant meer 
C. perfringens stammen uit klinische uitbraken inhibeerden de groei van de andere 
C. perfringens stammen in vergelijking met C. perfringens stammen geïsoleerd uit de darm 
van gezonde dieren. Naast toxine productie zou groei-inhibitie een virulentie eigenschap 
kunnen zijn die bijdraagt tot de eigenschap van bepaalde C. perfringens stammen om 
necrotische enteritis te induceren in vleeskippen. De secretie van factoren die de groei 
inhiberen van andere C. perfringens stammen kan leiden tot proliferatie en selectieve 
aanwezigheid van een stam die de genetische eigenschappen heeft om toxines uit te scheiden 
die darmletsels veroorzaken. 
 
In het laatste hoofdstuk (Chapter 3.3) wordt de opzuivering en karakterisatie van een groei-
inhiberende factor beschreven. De bacteriocine-achtige inhibitorische factor werd 
opgezuiverd uit het supernatans van een C. perfringens stam geïsoleerd uit een kip met 
necrotische enteritis. Deze stam vertoonde antibacteriële activiteit tegen andere C. perfringens 
stammen. Aminozuur sequentie analyse toonde aan dat de factor een 11.5 kDa groot fragment 
van een proteïne van 22 kDa en dat de factor het C-terminale deel van dit proteïne is. Het 
22 kDa proteïne is een cytoplasmatisch membraan proteïne zonder signaal sequentie. Na 
incubatie met de proteolytische enzymen trypsine en proteinase K of na hittebehandeling 
(10 min, 80 °C) werd geen antibacteriële activiteit meer waargenomen. De inhibitorische 
activiteit was stabiel bij een brede pH range (4.00 tot 10.00). Aangezien de intra-species 
antibacteriële activiteit van de opgezuiverde bacteriocine-achtige inhibitorische factor een 
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nauwer spectrum had dan het ruwe supernatans van de producerende stam, kan verondersteld 
worden dat deze stam meerdere dergelijke bacteriocine-achtige factoren aanmaakt. 
  
De resultaten van deze thesis hebben geleid tot een beter inzicht in de pathogenese van 
C. perfringens geïnduceerde necrotische enteritis bij vleeskippen. Er werd aangetoond dat 
slechts een subpopulatie van C. perfringens type A in staat is necrotische letsels te induceren. 
Onze resultaten tonen voorts aan dat het feit dat slechts één kloon teruggevonden wordt bij 
vleeskippen met necrotische enteritis waarschijnlijk te wijten is aan de secretie van groei-
inhiberende factoren, ook bacteriocines genoemd, gesecreteerd door C. perfringens type A 
stammen die pathogeen zijn voor de kip. Dit levert belangrijke informatie die waardevol zal 
zijn om meer efficiënte bestrijdingsstrategieën te ontwikkelen. 
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